ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0061333;renal tubule morphogenesis;6.0;0.7192862368539868;0.682763431017138;8.801845679307654;32.20947323359611;6.943860283624253;0.0010780220824845236;0.6782296504172152;[PKD2]
GO:0036499;PERK-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;80.02054155744251;7.292166977892469;0.0026782155121157316;0.6960420709600095;[EIF2AK3, EIF2S1]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[EIF4A3, CIB1, BPTF]
GO:0034198;cellular response to amino acid starvation;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;115.90251486529202;5.970411137910149;0.003879152867050031;0.6562464685024372;[BECN1, CDKN1A, SEH1L, EIF2AK3, EIF2S1]
GO:0019919;peptidyl-arginine methylation, to asymmetrical-dimethyl arginine;12.0;1.0;0.9481203125901445;9.628524252492122;368.02896848548767;7.697632086000634;0.012317598370641256;0.8417775754447168;[PRMT3]
GO:1902430;negative regulation of amyloid-beta formation;8.0;1.0;0.875;9.628524252492122;443.73862177950616;7.57984905034425;0.014851532332127743;0.7626338329336335;[PRNP]
GO:1903526;negative regulation of membrane tubulation;7.0;1.0;0.8509193652572005;9.628524252492122;66.13488992371046;9.083926447120524;0.0022134752482098636;0.8154717862087246;[WASL]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[AGPAT5, SFRP1, COL24A1, XRCC5, SIN3A, HOXB4, MIXL1]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[PER2, SFRP1, ARL2BP, CCL5, ITPR2, ARNTL]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[ERN1, P2RX7, DUSP5, KARS, PDE6H, TAOK2, RIPK1, CCL19, THBS1, MAPK8IP3]
GO:1902309;negative regulation of peptidyl-serine dephosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;774.5053809719614;8.67846133901236;0.025921998091542366;0.8590579283277371;[SWAP70]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[VAMP8, HLA-A, HLA-F, TAPBP]
GO:0098970;postsynaptic neurotransmitter receptor diffusion trapping;6.0;1.0;0.8231203125901445;9.628524252492122;48.92601517368421;7.697632086000634;0.00163750969730826;0.7167775754447168;[GPHN]
GO:0030705;cytoskeleton-dependent intracellular transport;5.0;0.5960880403619941;0.5882850320419173;7.885554947433499;33.20429938101479;4.695669262696007;0.0011113180183532213;0.5303777563261461;[WASL, TRAK1, FNBP1L, RAB21, FXR1, AP3M1, ARHGAP21, TUBA1C, CLN3, TUBA1B, RHOT2, SPAST, RHOT1, KIF13B, RAB6A, TNPO1, SPG11, IFT122, KIF23, WDR34, DYNLL2, CCDC88A, KIF4A, CLUAP1, PAFAH1B1]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[HDAC3, PKD2]
GO:0034063;stress granule assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.30488678463786;7.069023426578259;0.0035913979925534566;0.7124295520356204;[ATXN2, EIF2S1]
GO:0035278;miRNA mediated inhibition of translation;10.0;1.0;0.9152410118609203;9.628524252492122;1334.2752399667174;7.292166977892469;0.04465699151193064;0.7881627702307852;[TNRC6A]
GO:1903531;negative regulation of secretion by cell;7.0;0.5480059892447966;0.6249223598795988;7.5808314091268665;107.96086049134269;4.606589632642318;0.0036133528421788594;0.5865005732988543;[PPP1R11, RHBDF2, IDH2, PTPN22, BCR, RAP1B, VAMP8, TRIM9, ABR, NLRP12, SFRP1, NLRP7, NLRP3, CCR2]
GO:2000370;positive regulation of clathrin-dependent endocytosis;9.0;1.0;0.896240625180289;9.628524252492122;226.36966561352764;8.16763571524637;0.0075763889886123065;0.8139338954918922;[WASL]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[FGA, ARPC2, C1QBP, FGG, CIB1, UNC13D, LIMS1, S100A10]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[DCLRE1A, DCLRE1C, CCNH, MUM1, CIB1, YY1, MYC, EP300, NEK1, GTSE1, AQR, TIPIN, FBXO18, NSMCE2, NEIL3, MSH3, DDIT4, TIMELESS, COPS7B, COPS7A, XPC, RAD51AP1, NUAK1, CCNB1, RAD21, USP51, FANCI, XRCC6, UBE2B, XRCC5, INTS3, NONO, CNOT10, CDC7, FANCE, SETX, CDK9, CNOT4, CNOT6, COPS5, NPLOC4, CNOT7, CNOT1, UBE2T, BCL3, CNOT3, CDK2, INTS7, CNOT8, MNAT1, USP36, FEN1, BTG2, CDKN1A, SMG1, WDR48, MCM10, BRCA1, AATF, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, CASP2, CTLA4, TOPBP1, RFC5, UPF1, RFC3, RFC4, DTX3L, RFC1, NCOA6, PARP2, RAD23A, TFIP11, MASTL, DDB1, RAD51C, TFDP1, TFDP2, PCNA, PNKP, TANK, UNG, TFPT, FZR1, WRN, POLR2B, RBBP5, RAD54L, POLR2G, BID, E2F7, E2F8, POLQ, EYA2, GINS4, DONSON, APEX2, GTF2H4, SMUG1, HIST3H2A, RAD51, TTC5, POLE2, TAOK2, POLE3, MNDA, ERCC5]
GO:0051653;spindle localization;4.0;0.7866048967936545;0.6433024483968273;9.223059144383958;22.024791997814198;5.9928839937622085;7.371499671409332E-4;0.5564763661386056;[NSFL1C, ACTR2, ESPL1, WASL, KPNB1, CLASP1, NDC80, PAFAH1B1, MCPH1]
GO:0071480;cellular response to gamma radiation;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;6.444869117505266;0.0020214916980741903;0.6805102716434839;[CDKN1A, WRN, XRCC6, XRCC5, POLE3, ELK1, HRAS]
GO:0051894;positive regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;280.4986055833795;6.599019797332524;0.009388035896519984;0.712474179321389;[SFRP1, LIMS1, S100A10]
GO:0071481;cellular response to X-ray;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;7.379178354882098;0.0020214916980741903;0.728290889492758;[NIPBL, SFRP1, XRCC6, XRCC5]
GO:0030814;regulation of cAMP metabolic process;9.0;0.7140352122741334;0.7532582313173557;9.245532000236016;212.55514157362143;5.407625775213448;0.00711402930126111;0.6727868588050205;[TBL1XR1, CALM3, CALM1, PKD2, CALM2, CRHR1, TSHR, CCR2]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP153, RGPD1, IPO4, NUP93, IPO8, IPO9, NUP62, LMNA, HEATR3, TNPO1, TNPO2, RAE1, KPNB1]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[ACTR2, ARPC2, ROCK2, ARPC1A, AP2S1, WASL, EPHA1, EFNA4, HRAS]
GO:0072579;glycine receptor clustering;8.0;1.0;0.875;9.628524252492122;45.884964450884205;9.777073627680469;0.0015357284663841083;0.875;[GPHN]
GO:0072214;metanephric cortex development;5.0;1.0;0.7902410118609202;9.628524252492122;29.097465286989518;9.777073627680469;9.738659771369212E-4;0.7902410118609202;[PKD2]
GO:2000369;regulation of clathrin-dependent endocytosis;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;48.89431814385217;6.8867018697843045;0.0016364488262452562;0.7271862538851576;[WASL, SMAP1]
GO:0072218;metanephric ascending thin limb development;9.0;1.0;0.896240625180289;9.628524252492122;197.78996342219313;8.390779266560578;0.0066198520763304245;0.8253454670833372;[PKD2]
GO:1900272;negative regulation of long-term synaptic potentiation;9.0;1.0;0.896240625180289;9.628524252492122;54.24497338163739;7.57984905034425;0.0018155304417768478;0.7838744581139225;[PRNP]
GO:0043928;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;11.0;0.9326813400603323;0.8987696223598284;9.60383163990175;718.8643508040237;6.280566066213989;0.024059742885497587;0.7536173930320365;[HBS1L, CNOT6, CNOT7, SKIV2L, CNOT8, LSM5, DCP1A, EXOSC3, DCPS, DCP2]
GO:0071280;cellular response to copper ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.518977089658987;0.0026274528238337297;0.6565011041187423;[BECN1, PRNP, MT1G, ATP7A, AQP1]
GO:0000398;mRNA splicing, via spliceosome;11.0;0.8259837884571596;0.845420846558242;9.4949928598676;356.66873027722005;4.19357731889877;0.011937381421361158;0.6468886914394342;[SF3B5, SF3B2, WBP4, EIF4A3, DDX23, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PABPN1, PCF11, U2AF2, POLR2B, DHX16, SNRPB2, POLR2G, SMNDC1, DCPS, RBM5, AQR, PRPF38A, RBM15, GPKOW, BUD31, CPSF3, NONO, CPSF2, TFIP11, LSM5, SRRM1, PSPC1, PRPF3, SNRPG, CD2BP2, SLU7]
GO:0000045;autophagosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;62.10424204613046;5.769740442447999;0.0020785730910948433;0.618185107137305;[BECN1, NSFL1C, GABARAPL1, TP53INP2, TP53INP1, UBQLN1, PIK3C3, ATG5]
GO:0006814;sodium ion transport;7.0;0.811012628672052;0.7564256795932265;9.310070521373587;34.16983994150393;4.629579150867016;0.001143633791982704;0.5876762583299873;[SLC5A6, SLC12A2, SLC23A2, COMMD9, SLC9A6, SLC20A1, COMMD3, SLC38A6, PKD2L1, ATP1B2, PKD2]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, ENDOG, CPNE2, ECT2, ARID1A, RASGRP2, TUBG1, PKD2]
GO:0002218;activation of innate immune response;8.0;0.622025257344104;0.686012628672052;8.529911963824013;265.7077617868092;4.551326953967268;0.008892999665543976;0.6077550720842344;[COLEC12, ITGB2, NLRC4, LILRA2, TANK, RELA, HSP90B1, SIN3A, EP300, RIPK1, HRAS, HAVCR2, FGA, CREBBP, XRCC6, FCER1G, XRCC5, NONO, FGG, TMEM173, NFKB1, NFKBIA, ITCH, TNIP2, PSPC1, PIK3C3, KRAS, CARD11]
GO:0048026;positive regulation of mRNA splicing, via spliceosome;10.0;0.9326813400603323;0.8815816818910864;9.593432932680852;1178.6990535440698;6.686031174322154;0.03944999656184221;0.7571649570480019;[RBM3]
GO:0072365;regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter;12.0;0.8933024483968273;0.8947715367885583;9.57973408832269;2138.78857114633;9.777073627680469;0.07158332869152124;0.9481203125901445;[NCOR2]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[BTG2, CDKN1A, PCNA, CNOT10, PKD2, CNOT4, CNOT6, CCNB1, TFDP1, RBL1, CNOT7, TFDP2, CNOT1, CTDSP2, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8, DACT1, EZH2]
GO:0071158;positive regulation of cell cycle arrest;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;83.12201169572153;5.395046993006588;0.002782018926502022;0.6268223193749;[ZBTB17, BTG2, CDKN1A, PCNA, CNOT10, BRCA1, PKD2, CNOT4, CNOT6, CCNB1, TFDP1, CNOT7, TFDP2, FAP, CNOT1, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:0060391;positive regulation of SMAD protein signal transduction;8.0;1.0;0.875;9.628524252492122;234.98809543662418;7.292166977892469;0.007864840078708074;0.747921758369865;[NUP93]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[BCR, TFAP2A, BECN1, CAV1, CTNS, BRCA1, AATF, SIRT2, ATG5]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[P2RX7, P2RX4, HSP90B1]
GO:1903799;negative regulation of production of miRNAs involved in gene silencing by miRNA;10.0;0.8933024483968273;0.861892236059334;9.5758805190067;949.8698671053862;7.697632086000634;0.031791289624636974;0.8088982747154926;[NCOR2, NCOR1]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[PRNP, CDK5, IGF1R]
GO:1901379;regulation of potassium ion transmembrane transport;8.0;0.6369964171292115;0.6934982085646058;8.679443697794976;69.40502590152681;5.514393750639154;0.002322923756456068;0.6570063528532206;[PRNP, GAL, CAV1, NPPA, OXSR1, ATP1B2, NETO2]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[APOBEC3F, DTX3L, IL23A, SIN3A, IL27, TMEM173, IL12RB1]
GO:0000289;nuclear-transcribed mRNA poly(A) tail shortening;10.0;0.9326813400603323;0.8815816818910864;9.603206444507832;717.2549128915896;6.686031174322154;0.0240058764469685;0.7571649570480019;[CNOT4, CNOT6, PAN3, CNOT7, CNOT1, CNOT3, CNOT10, CNOT8]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[MTPN, BAG3, ITGA2, NPPA, CASP2, TNFRSF10B, TNFRSF10A, NFKB1, AQP1]
GO:0072235;metanephric distal tubule development;9.0;1.0;0.896240625180289;9.628524252492122;198.8885757108596;9.777073627680469;0.006656621640945223;0.896240625180289;[PKD2]
GO:0000290;deadenylation-dependent decapping of nuclear-transcribed mRNA;10.0;1.0;0.9152410118609203;9.628524252492122;717.2549128915896;7.474488534686424;0.0240058764469685;0.7974867031240476;[PAN3, CNOT7, DCP1A, DCPS, DCP2]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[ERN1, XBP1, TNFRSF10B, BBC3]
GO:2001234;negative regulation of apoptotic signaling pathway;8.0;0.6913464685778243;0.7206732342889122;9.146686165599384;292.02860154420875;4.420487353008457;0.00977393448500626;0.601063928806537;[FGA, PRELID1, XBP1, EYA2, WFS1, NONO, FGG, SYVN1, PLAUR, TNFRSF10B, TNFRSF10A, BRCA1, THBS1, RELA, CREB3, HSPH1, QARS, LMNA, VDAC2, RIPK1, HYOU1, RFFL, BID, TRIM32]
GO:0021915;neural tube development;5.0;1.0;0.7902410118609202;9.628524252492122;33.009488292418915;6.409777797693995;0.0011047978665365144;0.618037346520142;[PKD2, DACT1]
GO:0036295;cellular response to increased oxygen levels;5.0;0.9326813400603323;0.7565816818910864;9.533214072687796;50.196052919856044;7.138016298065211;0.0016800167177128669;0.6552794972956795;[CAV1, ATP6V0A2]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, AHCYL1, RPL3, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TBC1D2B, MYO7A, SYTL3, BCR, NUP93, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, COPB2, COPA, VPS26B, HSP90B1, VPS11, RAB6A, VPS16, PMM1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, HYOU1, ARF3, TRAM1, YWHAB, SRP54, CLTA, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, ARL5A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SSR2, TBC1D8, ACOX2, AGPS, SLU7, RABGAP1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, LMNA, AP2S1, HEATR3, STX5, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, SEC24C]
GO:0006887;exocytosis;6.0;0.6696747006330769;0.657957662906683;8.375761283996754;37.082880499217325;3.1596706497059923;0.0012411306378830758;0.4847060165558207;[SERPINA3, PYGB, SIGLEC9, WDR1, ITGB3, ITGB2, ABCA12, RPH3A, TRIM9, HK3, PSMD7, ACTR1B, SCRN1, PSMD2, LAMP2, PHACTR2, CTSH, SDF4, FAM3C, GUSB, SNAP29, FGA, ACTR2, SERPINB1, FCER1G, FGG, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SYTL3, SERPINB6, VAMP8, ACLY, EXOC3, VAMP4, DOCK2, ALDOA, VAMP5, SLC27A2, KPNB1, EXOC1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, THBS1, CORO1A, STX11, C3, RAP1B, CLEC3B, COMMD9, CCL5, PSMB1, NCKAP1L, A2M, RAB6A, ARFGEF2, XRCC6, TMEM30A, XRCC5, HSPA6, SURF4, SYT15, RAB27B, LILRB3, NFKB1, RAB11A, P2RX7, COPS5, SNX19, CDK5, FABP5, IMPDH2, VPS41, RAB18, CD9, PTX3, MNDA, DEGS1, MAN2B1, CALM1]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[TFRC, SLC22A17, MYC, ATP6V0A2, NEDD8, ACO1]
GO:0006635;fatty acid beta-oxidation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;579.9307786885206;5.734022359845919;0.019409761258888828;0.6894787953221185;[ECHS1, ABCD3, ACOX2, CPT2, HSD17B4, ETFA, ETFB, SLC27A2, HIBCH]
GO:0006878;cellular copper ion homeostasis;10.0;0.8653626801206646;0.8479223519212526;9.523163736834295;186.04478652569694;7.138016298065211;0.006226751575577643;0.7802794972956796;[PRNP, ATP7A]
GO:0071333;cellular response to glucose stimulus;8.0;1.0;0.875;9.628524252492122;272.3004295980195;5.69953618377475;0.009113650324169357;0.6664745454937787;[ERN1, XBP1, ENDOG, SIN3A, NME1]
GO:0070126;mitochondrial translational termination;7.0;1.0;0.8509193652572005;9.628524252492122;40.68669918132259;5.277263957350204;0.0013617472059468932;0.6207988894539612;[MRPL30, MRPL40, MRPS24, MRPS36, MRPS22, MRPS18B, MRPS18A, MRPL17, MRRF]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, DDX41, ZC3HAV1, LYST, RELA, NLRP3, IFNAR2, APOBEC3F, DTX3L, APOBEC3H, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, SERINC3, APOBEC3A, EXOC1]
GO:0016331;morphogenesis of embryonic epithelium;5.0;0.7369933605727446;0.6587376921472925;8.424551448166186;31.670476732859363;6.599019797332524;0.0010599823546702226;0.6277151911823093;[CFL1, GRSF1]
GO:0050999;regulation of nitric-oxide synthase activity;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;24.724602712185703;6.039404009397101;8.275102020790521E-4;0.6319757144917204;[CAV1, KRAS, WASL, CALM1]
GO:0016573;histone acetylation;11.0;0.6913464685778243;0.7781021866185744;9.117698628726131;658.0665084312584;5.152100814396198;0.0220248938157869;0.6959076275750737;[POLE4, DR1, CREBBP, CRTC2, IRF4, POLE3, EP300, YEATS4, TAF5]
GO:0070125;mitochondrial translational elongation;7.0;1.0;0.8509193652572005;9.628524252492122;106.95016378538953;5.299736813202263;0.0035795257329985885;0.6219481523473303;[MRPL30, MRPL40, MRPS24, MRPS36, MRPS22, MRPS18B, MRPS18A, MRPL17]
GO:0016575;histone deacetylation;9.0;0.7866048967936545;0.7895430735771163;9.396722638434797;357.60632662761185;5.682729065458369;0.011968761927426838;0.6868556538617572;[PER2, HDAC3, BRMS1, HDAC1, TBL1XR1, SIN3A, ARID4A, SUDS3, RBBP7, MTA2, SIRT2]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[USP36, USP37, PPP1R11, USP32, CCNF, USP34, KIF14, OTUD7B, BUB1B, UBE2Z, UBE2L3, PSMD8, TRIM9, CTSO, PSMD7, PSMD4, PSMD2, CDC26, CTSH, LONP2, SKP2, C18orf25, USP46, SEC13, RNF44, PDCD6IP, FBXO18, DTX3L, ARRDC1, RAD23A, TRPC4AP, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, CHMP4B, ANAPC5, MAN1B1, USP41, DERL3, RNF38, USP12, UBR4, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, RNF213, PSMB5, TP53INP2, UBD, PSMB1, UBQLN1, USP51, RFFL, RNF20, XBP1, UBE2I, TOR1A, SDF2L1, LRRC29, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, FAP, PSMC1, FBXL3, TRIM32, MAD2L1]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[TFAP2A, P2RX7]
GO:0060674;placenta blood vessel development;4.0;0.9326813400603323;0.7163406700301662;9.474373572664863;32.95974767671161;6.343086423195323;0.0011031330928924386;0.5743857346658935;[RBM15, TMED2, ARID1A, PKD2]
GO:0035195;gene silencing by miRNA;10.0;1.0;0.9152410118609203;9.628524252492122;181.23087468718478;7.379178354882098;0.006065634278582023;0.7926125360964777;[CNOT6, CNOT7, CNOT1, CNOT8, TNRC6A]
GO:0014032;neural crest cell development;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;64.99956039719687;6.558197802812269;0.002175476790687691;0.6256275524841266;[NOLC1, SOX8, KLHL12, KBTBD8]
GO:1901675;negative regulation of histone H3-K27 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1489.6293825007795;9.777073627680469;0.04985655485289462;0.9481203125901445;[SIN3A]
GO:1901796;regulation of signal transduction by p53 class mediator;7.0;0.7192862368539868;0.710562483684194;9.117698628726131;45.070113835906206;4.948759890378168;0.001508456149618737;0.6039991761920099;[TBP, CSNK2A1, RPS7, SENP2, BOP1, NUAK1, TTC5, TP53INP1, CDK2, TRIM24, TP53BP2, EP300, TAF7, TAF5, RFFL]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[COLEC12, DGKD, CD163L1, TFRC, WIPF2, ITGB3, ITGB2, STON1, CLTA, WASL, FNBP1L, RABEPK, LRP8, CORO1A, TM9SF4, HSP90B1, CLN3, KIAA1109, HSPH1, AP2S1, APOL1, SCARF1, HRAS, FCER1G, AMBP, FNBP1, CAV1, CDC7, UNC13D, MARCH3, NME1, RUFY1, GAK, SYNJ1, CDK5, SNX17, CD9, PIK3C3, HYOU1, DOCK2, MET, CSNK1G2, CSNK1G1]
GO:1904948;midbrain dopaminergic neuron differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;50.568000767972265;7.8311634786251565;0.0016924654774579861;0.7236063770733796;[RYK]
GO:0006777;Mo-molybdopterin cofactor biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.53008417967887;508.85275425180583;7.9853141584524145;0.01703084374706095;0.7592887026755414;[GPHN]
GO:0060315;negative regulation of ryanodine-sensitive calcium-release channel activity;11.0;1.0;0.9324289523296623;9.628524252492122;2557.621706734507;7.379178354882098;0.08560129681430756;0.8098004765652196;[CALM3, CALM1, PKD2, CALM2]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[RPL39L, HBS1L, RPS9, NDUFA7, RPL3, MRPS24, RPS7, MRPS36, MRPS18B, MRPS18A, RRBP1, RPL23A, RPL3L, RPS15, COPS5, RPL36AL, RPL7L1, RPL22L1, RPL29, MRRF, RPL19, CPEB4]
GO:0007616;long-term memory;7.0;1.0;0.8509193652572005;9.628524252492122;22.22653164046661;6.221725566191056;7.439020114266185E-4;0.6690987000520388;[PRNP, CAMK4, CTNS]
GO:0006649;phospholipid transfer to membrane;8.0;1.0;0.875;9.628524252492122;69.08120064785359;9.083926447120524;0.002312085616639433;0.839552420951524;[P2RX7]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, COPA, DCTN4, GOSR1, DCTN3, KLHL12, RAB43, SPAST, TFG, TMED2, STX5, TMED1, TMED4, TRAPPC2, TRAPPC3, TMED9, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, ARCN1, TBC1D20, TRAPPC6B, GOLGB1, HYOU1, SEC24C, SEC22C]
GO:1904938;planar cell polarity pathway involved in axon guidance;10.0;1.0;0.9152410118609203;9.628524252492122;101.1209235010256;8.16763571524637;0.003384426306656586;0.8329342821725234;[RYK]
GO:0070230;positive regulation of lymphocyte apoptotic process;9.0;0.7508913569872202;0.7716863036738992;9.158520623246385;129.55471920493628;6.8867018697843045;0.0043360798601117054;0.7484268790654467;[P2RX7, PRELID1, CCL5, PDCD1]
GO:0071320;cellular response to cAMP;7.0;1.0;0.8509193652572005;9.628524252492122;327.37290077043656;5.825829909099042;0.01095687637230394;0.6488525777373224;[RAP1B, IGFBP5, ITPR2, PKD2, AQP1]
GO:0014029;neural crest formation;6.0;1.0;0.8231203125901445;9.628524252492122;35.87688261436843;7.8311634786251565;0.0012007669740048141;0.7236063770733796;[NOLC1, KLHL12, KBTBD8]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, GRIPAP1, SYS1, FCER1G, ROCK2, ZDHHC23, ABCA12, RAB11A, GAK, SLMAP, RAB13, TMED2, VAMP5, RAB8B, S100A10]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[CSK, ATG5]
GO:0006740;NADPH regeneration;11.0;0.9326813400603323;0.8987696223598284;9.593432932680852;305.5875104430728;8.67846133901236;0.010227738963625468;0.8762458687964789;[NNT]
GO:1904953;Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation;8.0;0.8653626801206646;0.8076813400603323;9.427853557029971;31.415129658942366;7.474488534686424;0.0010514361179036673;0.7572456912631272;[RYK]
GO:1902775;mitochondrial large ribosomal subunit assembly;8.0;1.0;0.875;9.628524252492122;66.59596265062147;8.67846133901236;0.002228906937441061;0.8188169164668168;[DHX30]
GO:0061314;Notch signaling involved in heart development;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;57.16383262977075;7.57984905034425;0.0019132220340090946;0.738553198190834;[GALNT11]
GO:0006744;ubiquinone biosynthetic process;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;357.5406619598991;7.004484905440688;0.011966564190092859;0.7091290490632969;[COQ3, COQ9, COQ10B]
GO:0006621;protein retention in ER lumen;8.0;1.0;0.875;9.628524252492122;48.69704458819814;7.57984905034425;0.0016298462578721894;0.7626338329336335;[ANKRD13C, GPAA1]
GO:0050892;intestinal absorption;4.0;0.811012628672052;0.655506314336026;9.176539128749065;23.07461412231494;6.375876246018314;7.722865688694012E-4;0.576062607729944;[VIL1, ACO1, TJP2]
GO:0006977;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;11.0;1.0;0.9324289523296623;9.628524252492122;888.119660647831;5.75172193694532;0.0297245657860804;0.7265722796674696;[BTG2, CDKN1A, PCNA, CNOT10, CNOT4, CNOT6, CCNB1, TFDP1, CNOT7, TFDP2, CNOT1, CNOT3, CDK2, CASP2, EP300, CNOT8, GTSE1, E2F7, E2F8]
GO:0071470;cellular response to osmotic stress;5.0;0.6997970393407541;0.6401395315312973;8.986670366319727;76.3083833169515;6.409777797693995;0.002553972916532016;0.618037346520142;[ERRFI1, XRCC6, XRCC5, OXSR1, PKD2, SERPINB6, AQP1]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN3, FBXL15, PKMYT1, MASTL, TUBG1, CKAP5, CDC25A, CIT, CCNB1, WEE1, PPME1, CENPJ, CEP70, CDK2, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0071475;cellular hyperosmotic salinity response;7.0;0.9326813400603323;0.8172600352873667;9.567899630675686;243.83975882422638;8.390779266560578;0.008161097286311265;0.7800242071602487;[XRCC6, XRCC5]
GO:0045078;positive regulation of interferon-gamma biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.212124270218933;0.027942676825076673;0.7438283705770736;[EBI3, CEBPG, IL27]
GO:0070145;mitochondrial asparaginyl-tRNA aminoacylation;12.0;1.0;0.9481203125901445;9.628524252492122;531.0258213811239;9.777073627680469;0.017772956349414365;0.9481203125901445;[DARS2]
GO:0000083;regulation of transcription involved in G1/S transition of mitotic cell cycle;10.0;0.8933024483968273;0.861892236059334;9.541512875502493;264.067998117236;6.444869117505266;0.008838118251214853;0.7448319182472036;[KLF11, TFDP1, PCNA, TFDP2, CCNE1, GFI1, FBXO5, E2F7]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[CDKN1A, USP37, MAX, GMNN, MCM10, PPP6C, GPR132, PPAT, MYC, SKP2, CDKN2C, CDC7, CDC25A, POLE4, WEE1, CDK6, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, MCM6, MNAT1, MCM2]
GO:0031937;positive regulation of chromatin silencing;11.0;0.8259837884571596;0.845420846558242;9.478992518521158;424.62505234881525;7.697632086000634;0.014211818364378214;0.8260862151842345;[SETDB1, SIN3A]
GO:0071359;cellular response to dsRNA;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;141.5689593603356;6.781341354126479;0.004738185665998763;0.6699184248047958;[COLEC12, P2RX7, CAV1, TMEM173, NFKB1]
GO:0050658;RNA transport;7.0;0.6393367784920305;0.6705877545032157;8.391761625343195;40.09103529276204;4.488806596985934;0.0013418108716594672;0.5804771433779154;[AHCTF1, SMG1, SEH1L, POLDIP3, EIF4A3, CASC3, SUPT6H, SMG5, RPS15, ATXN2, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, XPO5, NUP43, RAE1, UPF2, UPF1, SEC13, CPSF3, CPSF2, NUP153, THOC2, SENP2, CKAP5, SRRM1, THOC6, NUP93, MCM3AP, SIDT1, SLU7]
GO:0045070;positive regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.31211810933421;6.221725566191056;0.0028553198171978322;0.6931793347948383;[DDB1, CNOT7, TBC1D20, CCL5, RAD23A, PPID]
GO:0045190;isotype switching;12.0;0.8259837884571596;0.8611122068187244;9.517298617381897;267.39842152832483;6.943860283624253;0.00894958452559752;0.8032296504172152;[EXO1, SWAP70, EXOSC3]
GO:0060339;negative regulation of type I interferon-mediated signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.593432932680852;528.6118652587121;7.57984905034425;0.017692163410416704;0.7626338329336335;[CNOT7]
GO:0031929;TOR signaling;6.0;0.8653626801206646;0.7558016526504768;9.377209824211215;26.42836680105094;6.518977089658987;8.845336528452411E-4;0.6565011041187423;[FLCN, CCDC88A, CLEC16A, CARD11]
GO:0060213;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;11.0;1.0;0.9324289523296623;9.628524252492122;968.1421379136862;7.379178354882098;0.03240284608461468;0.8098004765652196;[BTG2, CNOT7, CNOT1, POLR2G]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[XBP1, ACOT7, ABCD3, ELOVL5, ELOVL6, BRCA1, LIAS, HSD17B8, PRKAB1, ACACA, ACLY, DEGS1, FADS1, MGLL]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[TFAP2A, PRNP, CDK5, ITGB2, DDIT4, TP53BP2, CASP2, ELK1, EIF2S1]
GO:0006513;protein monoubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.574457031221845;155.4032479663248;5.649939242635378;0.005201206855589802;0.704179167478338;[DDB1, RNF20, UBE2B, DTX3L, MGRN1, UBE2T, KLHL12, KBTBD8]
GO:0034080;CENP-A containing nucleosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;242.74046782674554;6.343086423195323;0.00812430500592325;0.7206263598461826;[CENPH, CENPK, POLE3, CENPL, OIP5, RBBP7, CENPP, ITGB3BP]
GO:0006995;cellular response to nitrogen starvation;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;176.14763520758262;7.212124270218933;0.005895502827818261;0.7197477358342742;[BECN1, GABARAPL1, ATG5]
GO:0006511;ubiquitin-dependent protein catabolic process;8.0;0.7369933605727446;0.7434966802863723;9.190269321560967;156.4521708431119;3.582668236575797;0.005236313360306564;0.5582178202295975;[USP36, USP37, PPP1R11, USP32, CCNF, USP34, KIF14, BUB1B, UBE2Z, UBE2L3, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, USP46, SEC13, RNF44, FBXO18, DTX3L, ARRDC1, RAD23A, TRPC4AP, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, USP41, DERL3, RNF38, USP12, UBR4, DERL2, NEDD8, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, RNF213, PSMB5, TP53INP2, UBD, PSMB1, UBQLN1, USP51, RFFL, RNF20, XBP1, UBE2I, LRRC29, UBE2B, KLHL25, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, TRIM32, MAD2L1]
GO:0030835;negative regulation of actin filament depolymerization;11.0;0.8653626801206646;0.8651102923899945;9.56398573135455;392.44243440254417;6.193554689224359;0.013134695104192271;0.7491676271663439;[VIL1, SWAP70, SPTB]
GO:0070370;cellular heat acclimation;6.0;1.0;0.8231203125901445;9.628524252492122;73.25124241526203;8.16763571524637;0.0024516531618006543;0.7408135829017477;[RBBP7]
GO:0071464;cellular response to hydrostatic pressure;6.0;1.0;0.8231203125901445;9.628524252492122;258.5732291216956;9.777073627680469;0.008654213277905156;0.8231203125901445;[PKD2]
GO:0070254;mucus secretion;6.0;1.0;0.8231203125901445;9.628524252492122;81.03163345254794;9.083926447120524;0.002712055847921282;0.7876727335416686;[VAMP8]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[P2RX7]
GO:0045089;positive regulation of innate immune response;7.0;0.5408746917014966;0.6213567111079488;7.77894521237524;173.7808589209889;4.201124524534153;0.005816288955466338;0.5657650688141469;[ANKRD17, COLEC12, ITGB2, PTPN22, NLRC4, LILRA2, TANK, RELA, HSP90B1, AP1G1, SIN3A, CCL5, EP300, RIPK1, IL12A, HRAS, HAVCR2, FGA, CREBBP, LAG3, XRCC6, FCER1G, CADM1, XRCC5, NONO, CAV1, FGG, TMEM173, NFKB1, VAV1, NFKBIA, ITCH, POLR3B, POLR3C, TNIP2, PSPC1, TREML4, PIK3C3, KRAS, CARD11]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, DEFB1, IL27, LYST, PPP6C, C1QBP, HAVCR2, FGA, FCER1G, DTX3L, WRNIP1, RNASE3, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, RELA, C2, C3, PRDX1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, APOBEC3F, APOBEC3H, XRCC5, NONO, NFKB1, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[CENPJ, CEP70, RAB3IP, DCTN3, MAPRE1, TUBG1, CKAP5, CLASP1, RAB11A, PAFAH1B1]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CCNF, PREP, BUB1B, UBE2Z, UBE2L3, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, MYC, LONP2, SKP2, C18orf25, RNF44, FBXO18, ARRDC1, TRPC4AP, KCTD5, CDC25A, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7B, COPS7A, ANAPC11, C2, HSP90B1, C3, VCPIP1, CCNB1, RHOT1, RNF213, UBD, NLRP3, USP51, RIPK1, AMZ2, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, LNPEP, ERLIN2, BTBD6, PGA3, PGA5, NFKB1, NFKBIA, NSFL1C, COPS5, RNF103, NPLOC4, FBXL3, TPP1, USP36, USP37, WDR48, PPP1R11, USP32, USP34, KIF14, OTUD7B, BRCA1, USP39, SENP6, POLB, TRIM9, CTSO, SCRN1, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, SENP2, JOSD1, SIRT2, DDB1, PSMA1, ESPL1, PIK3C3, MAN1B1, USP41, THOP1, BECN1, DERL3, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, CLN3, FZR1, PSMB5, TP53INP2, PERP, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, P2RX7, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP2, PSMC1, TRIM32, C1QC, MAD2L1, METAP2]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PDGFRB, FGA, CCL20, RYK, FGG, GPR55, CIB1, PTPN22, IGF1R, RAP1B, CD4, KARS, CCL5, CCL19, EPHA1, HRAS, MET, HAVCR2]
GO:0070257;positive regulation of mucus secretion;7.0;1.0;0.8509193652572005;9.628524252492122;117.31221734425756;7.9853141584524145;0.0039263343403711445;0.7592887026755414;[ATG5]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[RAB43, ACTR2, RAB20, CCL20, CCL5, VPS26B, CCL19, IL12RB1, HLA-DPA1]
GO:0071108;protein K48-linked deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;6.375876246018314;0.006860975150996652;0.7413036195908642;[VCPIP1, USP37, USP34, OTUD7B]
GO:0030951;establishment or maintenance of microtubule cytoskeleton polarity;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;65.29771360028688;8.390779266560578;0.002185455710074652;0.7522251544931926;[LMNA, KIF2C, CKAP5]
GO:1905664;regulation of calcium ion import across plasma membrane;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;138.2755146586044;8.390779266560578;0.004627957035739618;0.8253454670833372;[PRNP]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[RAB3B, AHCYL1, SYS1, RPL3, DGKD, TFRC, NCF1, ZDHHC6, IPO4, RAB43, RPH3A, RPS15, EIF4ENIF1, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, TBC1D22A, VPS18, GSTK1, RPS9, RPS7, ARRDC1, VPS33A, COG4, VPS33B, COG3, AP1B1, COG1, TBC1D2B, MYO7A, SYTL3, BCR, RUFY1, NUP93, RINT1, UNC50, CHMP4B, KIF20A, RPL29, SLC27A2, KPNB1, ACOT4, PPID, CARD11, COPB2, COPA, SUCNR1, VPS26B, ABCB9, HSP90B1, VPS8, VPS11, ATP6V0A2, NLRP3, ECT2, RAB6A, ATP6V1F, VPS16, BBS2, XBP1, TOR1A, PMM1, VTA1, RAB3IP, NUP153, RAB27B, TIMM44, NFKBIA, PAN3, NPLOC4, CDK5, BCL3, HYOU1, ARF3, TRAM1, AHCTF1, SFT2D3, YWHAB, SRP54, CLTA, LYST, TRAM2, GPR89B, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, PDCD6IP, DTX3L, SSR2, RHBDF2, FGG, TBC1D8, BTN3A2, SENP2, ARFGAP1, VAMP8, AFTPH, LSG1, GAL, ACOX2, AGPS, EXOC3, LCP2, CHMP6, SLU7, VAMP5, PAFAH1B1, EXOC1, SEC22C, RABGAP1, GOSR1, ZDHHC23, HSD17B4, ZDHHC24, DERL2, RRBP1, NLRC4, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, SNX25, LMNA, VPS52, AP2S1, HEATR3, STX5, VPS54, CCL19, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, ARFGEF2, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, CENPF, SPCS2, MCM3AP, SNX19, GPAM, SNX17, SNX14, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, APBA3, SEC24C]
GO:0038155;interleukin-23-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.57984905034425;0.00101047745553359;0.738553198190834;[IL23A, IL12RB1]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[DOCK11, WASL, FNBP1L]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[IL6, ARL2BP, IL23A, CCL5, IL12A]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[DIABLO, BAG3, TNFRSF10B, TNFRSF10A, BID]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN1A, CDKN2C, EI24, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, CDK5, SERTAD2, NPPA, RBBP7]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[TOP2B, C12orf57, LRFN4, ALS2, CDK5, NFIB, RYK, TAOK2, NPTX1, NEFH, PAFAH1B1]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[POLR3B, POLR3C]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[EBI3, CEBPG, PTPN22, IL27, IL23A, BCL3, HLA-DPB1, IL12A, IL12RB1, HRAS, CD244, CCR2, HLA-DPA1, HAVCR2]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, DCTN4, DCTN3, CLTA, KLC1, KIF15, HLA-DMA, HLA-DMB, ACTR1B, AP1G1, AP2S1, CTSE, HLA-DQA1, HLA-DPA1, LAG3, SEC13, FCER1G, AP1B1, KIF23, DYNLL2, CENPE, KIF4A, HLA-DPB1, KIF2C, HLA-DRB3, SEC24C]
GO:0018315;molybdenum incorporation into molybdenum-molybdopterin complex;8.0;0.811012628672052;0.780506314336026;9.310070521373587;151.8478999048328;9.777073627680469;0.005082212555577183;0.875;[GPHN]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[FGA, FGG, TNFRSF10B, RIPK1, TNFRSF10A, BRCA1, RFFL]
GO:0090503;RNA phosphodiester bond hydrolysis, exonucleolytic;8.0;0.8436909121759173;0.7968454560879586;9.466005322994347;231.13671471601307;6.166155715036245;0.007735937832006836;0.6903374900225189;[CNOT6, PAN3, CNOT7, XRN1, CNOT1, CNOT8, EXOSC3, DCPS, DCP2]
GO:0045814;negative regulation of gene expression, epigenetic;7.0;0.7671156992804218;0.7344772148974115;9.081980546124052;80.1036275103501;5.2552850506314295;0.0026809963241870454;0.6196748871422394;[HELLS, HIST3H2A, HDAC1, MTF2, H3F3A, RBBP7, JARID2, SUPT6H, SIRT2, EZH2, PHF19]
GO:0036085;GDP-fucose import into Golgi lumen;9.0;1.0;0.896240625180289;9.628524252492122;65.06689879330041;9.777073627680469;0.0021777305462046545;0.896240625180289;[SLC35C1]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[NCKAP1, TBCCD1, ITGB3, LST1, KIF14, THOC2, P2RX7, PARVG, VSIG1, TBC1D20, COL4A4, NCKAP1L, ECT2, EPHA1, SOX6, MET]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, CRTC2, DGKD, ITLN1, KCNA3, PKD2L1, NLRC4, PKD2, CLYBL, ACACA, GLS, SPAST, RXRA, RNF213, PPAT, RIPK1, ECT2, BID, VASP, POLQ, PRNP, PDCD6IP, KCND1, FCER1G, TOR1A, CAV1, ATPIF1, EIF2AK3, KCTD5, MARCKS, ALDH5A1, RAD51, P2RX4, KCTD10, IMPDH2, KCTD14, CHMP4B, ALDOA]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HIST1H2BO, TSPYL1, HIST1H2BJ, H3F3A, IPO4, CHAF1B, CHAF1A, CENPH, UBN1, CENPK, POLE3, CENPL, OIP5, RBBP7, TSPYL6, CENPP, ITGB3BP, MCM2, HIST1H2BC]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[CDK5, RYK]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[MTPN, NCKAP1, WDR1, ROCK2, WIPF2, ARPC1A, WASL, IQGAP2, CORO1A, AKAP13, ARHGDIB, CFL1, PPFIA1, NCKAP1L, ARFIP1, HRAS, CLASP1, S100A10, VASP, PDGFRB, ACTR2, SWAP70, SSH3, SPTB, CIT, VIL1, CCDC88A, SFRP1, ARPC2, CDK5, FES, TAOK2, EPHA1, MET, ARHGEF5]
GO:0051495;positive regulation of cytoskeleton organization;7.0;0.6240278086381567;0.6629332695762788;8.288749907007125;90.95714178965997;4.425215494204403;0.0030442536795868575;0.5772250914243793;[NCKAP1, WDR1, ROCK2, WIPF2, ARPC1A, WASL, IQGAP2, NUP62, CFL1, NCKAP1L, HRAS, CLASP1, S100A10, VASP, ACTR2, SWAP70, VIL1, P2RX7, NSFL1C, SFRP1, ARPC2, CDK5, FES, PFDN2, EPHA1, MAPRE1, MET, ARHGEF5]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[SFRP1, EPHA1, ARHGEF5, S100A10]
GO:0072177;mesonephric duct development;8.0;1.0;0.875;9.628524252492122;72.2335846832606;8.16763571524637;0.0024175930733430647;0.7926932703116032;[PKD2]
GO:0016240;autophagosome membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;8.390779266560578;7.158639954716971E-4;0.7193458537639684;[VAMP8, SNAP29]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[ERN1, BECN1, USP36, CDK5, CALCOCO2, CLEC16A, ATP6V0A2, CHMP4B, RAB3GAP2, VPS26B, RAB3GAP1, EXOC1]
GO:0016485;protein processing;6.0;0.6519675769143192;0.6491041010473041;8.320191432841943;99.81063536400724;4.720827822332161;0.0033405721418933456;0.564543666965156;[FGA, RHBDF2, FGG, P2RX7, CLN3, SPCS2, PERP, CASP2, CTSH, LONP2, PIK3C3, CTSE, SEC11A, SEC11C, METAP2]
GO:0051017;actin filament bundle assembly;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;39.792633402144126;5.734022359845919;0.001331823628924752;0.6163584827319739;[MARCKS, SWAP70, NEDD9, LCP1, HSP90B1]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CRTC2, DGKD, YWHAB, PKD2L1, IKZF1, PKD2, CLYBL, GLS, IGF1R, PPAT, NUP62, HRAS, PDCD6IP, KCND1, FCER1G, ATPIF1, PRKAB1, KCTD5, GCHFR, ALDH5A1, KCTD10, KCTD14, CHMP4B, ALDOA, COLEC12, ITLN1, KCNA3, NLRC4, HSD17B8, ACACA, SPAST, RXRA, RNF213, CCL5, NLRP3, RIPK1, ECT2, BID, S100A10, VASP, POLQ, PRNP, RRM1, SEPT11, XRCC6, CPSF6, TOR1A, CAV1, EIF2AK3, P2RX7, MARCKS, COL1A2, RAD51, P2RX4, IMPDH2]
GO:0040014;regulation of multicellular organism growth;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;36.77819272999274;5.557565922504363;0.0012309330124483187;0.5744551915910391;[BBS2, VIL1, ATRN, NIPBL, SGPL1, GPAM]
GO:0043409;negative regulation of MAPK cascade;10.0;0.7248374789738407;0.7776597513478407;9.36615998802463;1019.276674017434;4.7081694254602375;0.034114272989912375;0.6560170152312259;[ERRFI1, HDAC3, PTPN22, DUSP14, IGF1R, PPP2CA, FLCN, HSPH1, MYC, NUP62, STK38, PBK, CSK, DACT1, DUSP5, AMBP, CAV1, PAQR3, DUSP22, P2RX7, ITCH, NLRP12, SFRP1, NCOR1, QARS, PAFAH1B1]
GO:0006421;asparaginyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;8.67846133901236;0.006875708083302461;0.8762458687964789;[NARS, NARS2, DARS2]
GO:0042311;vasodilation;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;40.37281764308888;6.599019797332524;0.0013512418733372556;0.712474179321389;[BBS2, ATG5]
GO:0042795;snRNA transcription by RNA polymerase II;12.0;1.0;0.9481203125901445;9.628524252492122;1410.6487555617684;5.528578385631111;0.047213144347195396;0.730852068336507;[ZNF143, TBP, ELL, INTS3, INTS10, GTF2E2, CDK9, POLR2B, SP1, INTS4, POLR2G, INTS7, TAF5]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, MAML1, CCNH, GFI1, ARID4A, RORA, YEATS4, IKZF1, IKZF2, ELK1, YY1, RPS6KA4, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, MAX, RLF, SUPT6H, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, PKD2, FLCN, NIPBL, SIN3A, HRAS, ZNF485, KLF13, RBM15, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, RELA, ARNTL, RXRA, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, NFIA, NFIB, TNIP2, TTC5, NFIC, PSMC1, TAF7, CAMK1, MIXL1]
GO:0006425;glutaminyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;9.083926447120524;0.006875708083302461;0.8969813732811862;[QARS]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[TFAP2A, PRNP, CDK5, CASP2]
GO:0006664;glycolipid metabolic process;6.0;0.6023560406934092;0.6242983329368491;8.337540071176557;77.09560371581999;5.152100814396198;0.002580320474829782;0.586598987835556;[GALC, UGT8, CLN3, DPM3, ALDH5A1, KDELC2, GBA2]
GO:0045821;positive regulation of glycolytic process;12.0;0.8933024483968273;0.8947715367885583;9.592156608321247;4823.688028610602;6.8867018697843045;0.1614444972802151;0.8003065664753022;[P2RX7, ARNT]
GO:0006417;regulation of translation;7.0;0.5221699919663294;0.6120043612403652;8.01908634005802;212.8215771898108;3.9901762463137618;0.007122946661558481;0.554977164055858;[MTPN, BTG2, EIF4E3, POLDIP3, EIF4A3, NOLC1, CASC3, THBS1, FXR1, RBM3, EIF4ENIF1, ATXN2, RXRA, C1QBP, CCL5, TPR, MKNK2, POLR2G, UPF1, EIF5B, EIF2B4, RPS9, KLHL25, IGFBP5, YTHDF3, ITGA2, EIF2AK3, CNOT10, EIF2S1, PER2, CNOT6, ILF3, IL6, CNOT7, XRN1, CNOT1, CAPRIN1, BCL3, CNOT3, ETF1, ACO1, EIF4E2, CNOT8, KBTBD8, EIF4G2, TNRC6A, CPEB4]
GO:0010918;positive regulation of mitochondrial membrane potential;5.0;1.0;0.7902410118609202;9.628524252492122;24.658349685322438;7.57984905034425;8.252927728937918E-4;0.6778748447945537;[NNT, CTNS, BID]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[PRNP, LAG3, HOMER3, HAVCR2]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[PRNP, NCKAP1L, IL12A]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, GABARAPL1, CALCOCO2, VTA1, EI24, DYNLL2, PRKAB1, CLN3, FUNDC1, UBQLN1, C6orf106, CHMP4B, PIK3C3, CHMP6, ATG5]
GO:0014054;positive regulation of gamma-aminobutyric acid secretion;9.0;1.0;0.896240625180289;9.628524252492122;403.17799630906705;8.67846133901236;0.013494004699825146;0.8400575416471059;[P2RX7, NTSR1]
GO:0036066;protein O-linked fucosylation;9.0;1.0;0.896240625180289;9.628524252492122;187.13222888987366;7.697632086000634;0.006263147292872048;0.7898978880348613;[SLC35C2, SLC35C1]
GO:0006310;DNA recombination;7.0;0.612588685250814;0.6572137078826075;8.529911963824013;149.0421272461911;4.488806596985934;0.0049883058697239;0.5804771433779154;[FEN1, WDR48, DCLRE1C, BRCA1, UNG, YY1, POLB, RAD51AP1, TFPT, NIPBL, WRN, EXO1, RAD21, RAD54L, EXOSC3, POLQ, XRCC6, ENDOG, FBXO18, NCOA6, XRCC5, NONO, SWAP70, GINS4, NSMCE2, APEX2, WRNIP1, CDC7, SETX, RAD51C, RAD51, MSH3]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CALM3, CALM1, PKD2, CALM2, CORO1A, NTSR1, ATG5]
GO:0097352;autophagosome maturation;5.0;1.0;0.7902410118609202;9.628524252492122;38.04764185170599;6.599019797332524;0.0012734203321220245;0.6277151911823093;[VAMP8, CLN3, GABARAPL1, SNX14, VPS33A, LAMP2, UBQLN1, SNAP29, VPS16]
GO:0097112;gamma-aminobutyric acid receptor clustering;8.0;1.0;0.875;9.628524252492122;45.884964450884205;9.083926447120524;0.0015357284663841083;0.839552420951524;[GPHN]
GO:0014049;positive regulation of glutamate secretion;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;414.8970628992697;7.474488534686424;0.013886231312124032;0.7784863164434164;[P2RX7, NTSR1, RAB3GAP1]
GO:0060044;negative regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;721.615529104109;7.292166977892469;0.02415182234730172;0.7881627702307852;[JARID2]
GO:0000819;sister chromatid segregation;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;40.65143508701015;6.221725566191056;0.0013605669484458803;0.6084203466557585;[TOP2B, ESPL1, ZNF207, CDCA8, TUBG1, SMC4, NDC80, ZWINT, MAD2L1]
GO:0006120;mitochondrial electron transport, NADH to ubiquinone;6.0;1.0;0.8231203125901445;9.628524252492122;32.64917349834284;5.9928839937622085;0.0010927384546410499;0.6295966787287501;[NDUFA7, NDUFB7, NDUFB10, NDUFS7, NDUFS6, NDUFA10, COQ9]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[TCERG1, ZNF175, ONECUT2, ELL, CCNH, INTS10, ARID4A, HOXC13, BRCA1, ELK1, AFF4, MYC, TRIM24, ZNF768, EP300, IER2, GTF2I, KLF11, TBP, KLF13, MKL1, ZBTB32, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, RFX4, TFEC, MED20, LCOR, WBP2, MAX, CEBPG, RPAP1, SUPT6H, GTF2E2, RELA, ARNTL, POLR2B, RAD21, TAF1A, HLTF, HIVEP1, HOXC4, POLR2G, HIVEP2, TFAP2A, POLR2J3, ZBTB17, ZNF143, XBP1, NFYC, INTS3, PBX3, EAF2, ARID3B, DEK, GRHL1, USF2, GTF2H4, FLI1, NFKB1, CDK9, GFI1B, STAG1, TFCP2, COPS5, NFIA, SP1, NFIB, NFIC, MAFF, NFE2L3, INTS4, TAF7, INTS7, TAF5, MNAT1, ZNF136, NFE2L1, MIXL1]
GO:1903206;negative regulation of hydrogen peroxide-induced cell death;9.0;0.8436909121759173;0.8180860812682478;9.589303539338841;500.078557460717;6.8867018697843045;0.01673717927672765;0.7484268790654467;[NUP93, HSPH1, PYCR1, MET]
GO:1903566;positive regulation of protein localization to cilium;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;74.11254383842964;8.390779266560578;0.002480480145313119;0.7800242071602487;[CCDC88A]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[RIC8A, CDK5, DDHD2, CTNS, KRAS]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CREBBP, CDKN1A, TBP, MAML1, CCNH, RORA, ZNF45, GTF2H4, MED6, RUNX2, GTF2E2, CDK9, RXRA, POLR2B, NPPA, MED20, TAF7, POLR2G, TAF5, MNAT1, GTF2I]
GO:0071294;cellular response to zinc ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.641579411751319;0.0026274528238337297;0.6627709925721352;[ZNF658, MT1G, KCNK3]
GO:0010614;negative regulation of cardiac muscle hypertrophy;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;95.68117633875403;6.8867018697843045;0.003202362864589963;0.7271862538851576;[ERRFI1, P2RX4, LMNA, JARID2]
GO:0010975;regulation of neuron projection development;8.0;0.5673924682959377;0.6586962341479689;8.404748820870006;84.29486529122617;3.652390236786265;0.0028212732808438556;0.5617834065627654;[GFI1, CIB1, TRAK1, LRP8, RAB21, FXR1, CFL1, KIF13B, DVL3, LRIG2, SCARF1, MARK2, ZNF365, SEMA6B, ACTR2, TMEM30A, PAQR3, THOC2, SSH3, RAB11A, NME1, SETX, GAK, OLFM1, CCDC88A, SFRP1, CDK5, FES, RUFY3, CAPRIN1, CAMK1, ADNP, PAFAH1B1, EZH2]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[P2RX7, ITPR2, CCL19, PKD2]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[UPF1, BTG2, IGFBP5, YTHDF3, EIF4A3, EIF2AK3, CNOT10, EIF2S1, FXR1, EIF4ENIF1, ILF3, CNOT7, XRN1, CNOT1, CAPRIN1, TPR, CNOT3, EIF4E2, CNOT8, TNRC6A, CPEB4]
GO:0010971;positive regulation of G2/M transition of mitotic cell cycle;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;355.9636244052406;6.481236761676141;0.011913782162380092;0.7276913745807394;[CCNB1, RAD51C, SIN3A, CDC7, RAB11A, CDC25A]
GO:1900181;negative regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.70504749320965;6.444869117505266;0.002500310709419936;0.6805102716434839;[FLCN, SIN3A, PKIA, OTUD7B]
GO:0044804;autophagy of nucleus;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;39.83166466328102;6.7325511899570465;0.0013331299701091492;0.6345439928109722;[BECN1, ATG5]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, GALNT11, SEPT11, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, RFX4, CENPJ, TMEM107, NEK1, CCDC65, SNAP29, CLUAP1]
GO:0007220;Notch receptor processing;6.0;1.0;0.8231203125901445;9.628524252492122;83.35257022185557;7.379178354882098;0.0027897355128825266;0.7004918368257019;[GALNT11]
GO:0042509;regulation of tyrosine phosphorylation of STAT protein;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;161.54069116905714;5.4730085344763;0.005406621556244977;0.6951309228349634;[PPP2CA, IL6, CNOT7, ARL2BP, IL23A, CCL5, CAV1, IL12A, IL22RA2]
GO:0060395;SMAD protein signal transduction;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;5.734022359845919;7.75488093814194E-4;0.5834791820027497;[NUP93, LNPEP]
GO:0007223;Wnt signaling pathway, calcium modulating pathway;9.0;1.0;0.896240625180289;9.628524252492122;33.206889128170424;6.250713103064308;0.001111404694859899;0.7159023839588838;[GNG2, GNAT2, CALM1, TNRC6A]
GO:0007221;positive regulation of transcription of Notch receptor target;12.0;1.0;0.9481203125901445;9.628524252492122;1467.8987330058965;6.8867018697843045;0.04912924957061573;0.8003065664753022;[CREBBP, RBM15, MAML1, EP300]
GO:0006378;mRNA polyadenylation;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;472.4435102429282;6.250713103064308;0.015812259116276064;0.734902770639515;[AHCYL1, CPSF6, PCF11, CPSF3, CPSF2, SSU72, GRSF1]
GO:0070072;vacuolar proton-transporting V-type ATPase complex assembly;8.0;1.0;0.875;9.628524252492122;45.210214189519135;7.474488534686424;0.0015131451823720294;0.7572456912631272;[ATP6V0A2, TM9SF4]
GO:0051574;positive regulation of histone H3-K9 methylation;11.0;0.8933024483968273;0.8790801765280758;9.571365838652174;804.3299673530898;7.474488534686424;0.02692020015733362;0.8146746435927894;[BRCA1, JARID2]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[BECN1, CDKN1A, SEH1L, MAX, CLEC16A, COMT, AQP3, HSP90B1, WRN, LAMP2, NUDT15, SKP2, FADS1, ATG5, GABARAPL1, XBP1, EIF2AK3, USF2, EIF2S1, P2RX7, SFRP1, TBL2, P2RX4, MARS, PIK3C3, ADNP, CPEB4]
GO:0072015;glomerular visceral epithelial cell development;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;35.73672554677016;7.474488534686424;0.0011960760430854717;0.7053660038532718;[NUP93]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[ZNF175, MAML1, CCNH, GFI1, EIF4A3, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, FLT3LG, PRKAB1, MED6, RUNX2, SFRP1, KARS, IL23A, RFX4, HOXB4, NOLC1, C3, FXR1, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZNF143, CREBBP, XBP1, XRCC6, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, NIPBL, C1QBP, TMED2, CTSH, HRAS, ZNF485, SEC13, NCOA6, TMEM173, PPRC1, SIRT2, GNL3, NCOR2, GAL, NCOR1, MTF2, TFEC, ZNF350, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, LMNA, GPBP1L1, ZNF462, YTHDF3, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, RAB3GAP1, MIXL1, LIMS1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, YY1, EP300, ZNF564, RPS9, RPS7, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, CCNB1, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, RHBDD1, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CIITA, ONECUT2, PTPN22, DDX41, PKD2, CKS1B, RBM3, FLCN, LBH, SIN3A, NUP62, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, ITGA2, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, POLR1E, MET, HDAC3, HDAC1, WBP2, ROCK2, POLDIP3, CEBPG, THBS1, CLEC3B, U2AF2, TP53INP2, CCL5, TP53INP1, TAF1A, POLR2G, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, ARID3B, DEK, USF2, P2RX7, CD4, TNIP2, TAF7, KRAS, FAM98A]
GO:0010869;regulation of receptor biosynthetic process;6.0;0.7369933605727446;0.6916169928765168;9.117698628726131;56.78929533504888;6.781341354126479;0.001900686607816435;0.6699184248047958;[ANKRD13C, HDAC1, ITGB3, SCAP]
GO:0033962;cytoplasmic mRNA processing body assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.30488678463786;7.212124270218933;0.0035913979925534566;0.7197477358342742;[ATXN2, CNOT7]
GO:0032873;negative regulation of stress-activated MAPK cascade;11.0;0.8436909121759173;0.8542744084176208;9.56534535087059;1526.0559120613332;6.039404009397101;0.051075718015538125;0.7412843542312382;[ITCH, SFRP1, HDAC3, NCOR1, HSPH1, AMBP, QARS, MYC, PBK, PTPN22, PAFAH1B1, DACT1]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[P2RX7, IL23A, IL12A, HLA-A, HLA-F, IL12RB1]
GO:0019433;triglyceride catabolic process;8.0;1.0;0.875;9.628524252492122;492.4915826757067;6.518977089658987;0.01648325005850736;0.7083807915285978;[FABP5, DDHD2, MGLL]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[P2RX7, IL6, XBP1, FCER1G, MBP]
GO:0051457;maintenance of protein location in nucleus;7.0;0.811012628672052;0.7564256795932265;9.292052015870908;48.00389740763819;6.686031174322154;0.0016066472455308106;0.692843310444282;[CDK5, ARL2BP, BCL3]
GO:0043967;histone H4 acetylation;12.0;0.8259837884571596;0.8611122068187244;9.464221201200845;659.4528027923784;5.825829909099042;0.022071291840469662;0.7460535250702665;[IRF4, EP300, YEATS4]
GO:0043966;histone H3 acetylation;12.0;0.7671156992804218;0.8316781622303555;9.3498108500231;659.4528027923784;5.926926025970411;0.022071291840469662;0.7512235851885185;[POLE4, DR1, CRTC2, IRF4, POLE3]
GO:0043968;histone H2A acetylation;12.0;0.8933024483968273;0.8947715367885583;9.55953138100517;659.4528027923784;7.004484905440688;0.022071291840469662;0.8063299963962409;[YEATS4]
GO:1902017;regulation of cilium assembly;8.0;0.7866048967936545;0.7683024483968273;9.34084218004034;85.2089877911262;5.926926025970411;0.002851868138258671;0.6781032725983739;[CCDC88A, CENPJ, VDAC3, EVI5L, ATG5]
GO:0042994;cytoplasmic sequestering of transcription factor;12.0;0.9326813400603323;0.9144609826203107;9.59462270081644;299.00248665445736;6.8867018697843045;0.01000734414355716;0.8003065664753022;[NFKBIA, PKD2]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, MAML1, CCNH, IL5RA, BUB1B, STK19, IGF1R, RPS6KA4, RPS6KA2, MYC, CFL1, TRIM24, NEK1, PDGFRB, CSNK2A1, PAQR3, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, EPHA1, CSNK1G2, CSNK1G1, PKMYT1, RASGRP4, STK3, NUAK1, CCNB1, STK35, STK38, STK38L, MBP, RIPK1, MARK2, EIF2AK3, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, CALM1, MNAT1, SMG1, FASTKD1, MAST3, YWHAB, AKAP13, ZMYM2, PBK, CTSH, HRAS, DUSP5, KSR1, CAD, OXSR1, MASTL, GFRA2, SPTB, CIT, GAK, ITPKB, PDIK1L, FASTKD5, PIK3C3, MET, HBEGF, ROCK2, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, GTF2H4, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, CAMK1]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[CDKN1C, ERRFI1, DUSP5, CDKN1A, CDKN2C, CAV1, PAQR3, CIB1, PTPN22, DUSP14, IGF1R, PPP2CA, DUSP22, SFRP1, CDK6, QARS, GNAQ, PKIA, NUP62, STK38, TAF7, CRIPAK, EPHA1, CHMP6]
GO:0042754;negative regulation of circadian rhythm;4.0;0.8259837884571596;0.6629918942285797;9.040737587590003;21.64841646219066;7.069023426578259;7.245530166796041E-4;0.6115101867784198;[PER2, SIN3A]
GO:0031659;positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle;13.0;1.0;0.9625549647676366;9.628524252492122;3325.2743974982595;7.8311634786251565;0.11129394153160196;0.8630410292508717;[PKD2]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[ERRFI1, EIF4A3, CIB1, RORA, GPATCH3, IGF1R, RGS1, MYC, WWC3, HOMER3, TLE4, PDGFRB, IGFBP5, ARRDC1, PAQR3, SLC35C1, RUNX2, PIAS2, SFRP1, TWSG1, RFX4, DDIT4, VDAC2, EPHA1, KLHL12, APCDD1, GLG1, STK3, RNF213, HSPH1, STK38, DVL3, NLRP3, RIPK1, PRNP, PRELID1, XBP1, UBE2B, AMBP, WFS1, NONO, CAV1, IFT122, TNFRSF10B, TNFRSF10A, ARHGAP25, NFKBIA, IL6, NPLOC4, CNOT7, QARS, CNOT1, BCL3, CALM3, CRIPAK, HYOU1, CALM1, CALM2, EZH2, ONECUT2, YWHAB, OTUD7B, PTPN22, BRCA1, PKD2, DUSP14, FLCN, LBH, C1QBP, NUP62, PBK, HIF1AN, DACT1, FGA, DUSP5, PVRIG, FGG, PLAUR, SENP2, DUSP22, CREB3, NCOR1, IRF4, TAX1BP3, CHMP6, MET, PAFAH1B1, HDAC3, HIST1H2BJ, HDAC1, MGRN1, LILRA2, THBS1, TANK, RELA, ARNTL, PPP2CA, SNX25, CCL5, LMNA, UBQLN1, CSK, RFFL, BID, EYA2, RYK, SYVN1, P2RX7, ITCH, NLRP12, PIK3IP1, TRIM32]
GO:0010955;negative regulation of protein processing;9.0;0.7192862368539868;0.7558837436072825;9.27570287786938;707.1969765737138;6.039404009397101;0.023669246369964203;0.705096027081865;[PRNP, NLRP7, NLRC4, A2M, UBE2Z, THBS1, GLG1]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[SETX, WRN, XRCC6, RAD51, FBXO18, XRCC5, GINS4, ASCC3, MCM6, CHD1, GTF2H4, MCM2]
GO:0017121;phospholipid scrambling;5.0;0.7980440201809971;0.6892630219514189;9.117698628726131;49.436230899548704;7.212124270218933;0.0016545861584886027;0.659069382437994;[P2RX7]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[SFRP1, UBE2B, RYK, MYC, DVL3, SDC1]
GO:1903351;cellular response to dopamine;8.0;1.0;0.875;9.628524252492122;545.6259493406901;7.138016298065211;0.018261609492958953;0.7400384854347593;[SIN3A]
GO:0042769;DNA damage response, detection of DNA damage;5.0;0.7866048967936545;0.6835434602577475;9.143016436710422;39.83823472227698;6.139487467954083;0.0013333498640710748;0.6042146864874571;[DDB1, RFC5, RFC3, WDR48, RFC4, PCNA, UBE2B, RFC1, PNKP, NEK1]
GO:0043619;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;12.0;0.811012628672052;0.8536266269261705;9.523163736834295;532.6985892857467;7.379178354882098;0.017828942385788714;0.825491836825702;[SIN3A, ARNT]
GO:0045919;positive regulation of cytolysis;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.08542638077049;7.379178354882098;0.0013750922464812324;0.6676125360964777;[P2RX7]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SND1, EID1, EWSR1, RFX4, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, ZNF136, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, JARID2, ZNF485, TSC22D4, HELLS, COMMD3, BAZ1A, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, GPBP1L1, ZNF101, ZNF462, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, NONO, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZNF658, NFE2L3, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, PHTF2, CIITA, ONECUT2, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, LCOR, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TBX1, POLR2J3, CHURC1, EYA2, ARID3B, DEK, USF2, POLR3B, POLR3C, TNIP2, POLR3E, TAF7, MNDA, TAF5]
GO:1903595;positive regulation of histamine secretion by mast cell;12.0;1.0;0.9481203125901445;9.628524252492122;1919.1459578632118;8.390779266560578;0.06423208809045369;0.8772251544931927;[VAMP8, NPPA]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[DUSP5, EYA2, SSU72, DUSP28, PTPN22, PPP2R5D, SSH3, CDC25A, PPM1G, DUSP14, PPP1CB, PTP4A1, PPP2CA, DUSP22, PPP1CC, DUSP23, PPP6C, MINPP1, PDPR, PTPRA, CTDSP2]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[TCERG1, ZNF175, MAML1, CCNH, GFI1, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, TIAL1, RPS6KA4, MYC, SAP130, ZXDC, DPF2, TRIM24, SOX8, FBXO5, SOX6, IER5, IER2, SAP30BP, CSNK2A1, ZNF282, SFMBT2, FLT3LG, HCFC2, SND1, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, KARS, IL23A, EWSR1, RFX4, BOLA3, HOXB4, TRIM14, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, COMMD9, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, H3F3A, PBX3, EIF2AK3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, QARS, GOLGB1, PKIA, ZNF30, ZNF136, EZH2, CDKN1C, SETD5, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, ATF7IP2, OTUD7B, HOXC13, ZNF45, BRCA1, WASL, AATF, WDR43, NIPBL, CHAF1B, ZMYM2, SCML1, C1QBP, CIC, JARID2, HRAS, HAVCR2, ZNF485, TSC22D4, HELLS, SEC13, NCOA6, SPHK1, PRMT3, COMMD3, BAZ1A, TMEM173, PPRC1, ZFX, MED29, SIRT2, VAV1, MED28, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, DEPDC1, VGLL4, ARHGEF5, ZNF350, PCNA, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, PPP2CA, SERTAD3, BCLAF1, RXRA, SERTAD2, UBN1, GPBP1L1, SCAND1, ZNF101, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, ITCH, NLRP12, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, LIMS1, ZNF331, CRTC2, NCF1, NAB1, CD80, GMNN, ARID4A, UBP1, CIB1, RORA, YEATS4, YY1, ADORA3, WWC3, ZNF207, EP300, SNIP1, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, PIAS2, ERN1, ARMCX3, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, CARD11, ZNF550, MAX, RLF, SUPT6H, GTF2E2, STK3, BAG3, TPR, ZNF549, ZNF548, DVL3, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, PRNP, DR1, UBE2I, WFS1, NONO, CAV1, CNOT10, NFKB1, CDK9, NFKBIA, CNOT6, IRAK1BP1, IL6, TFCP2, COPS5, CNOT7, CDK5, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, CNOT8, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, USP36, PHTF2, CIITA, ONECUT2, YWHAB, ITGB2, DDX41, PKD2, CHD1, AFF4, CKS1B, FLCN, LBH, SIN3A, ZNF407, NUP62, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, MET, ZNF630, ITGB3BP, MCPH1, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, NLRC4, LRP8, TFPT, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, ASCC3, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, RNF20, CHURC1, EYA2, FBXL15, ARID3B, DEK, USF2, CD4, POLR3C, TNIP2, TAF7, MNDA, KRAS, TAF5, TRIM32]
GO:0042760;very long-chain fatty acid catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;525.4628036644517;7.8311634786251565;0.017586767152828246;0.7967266896635242;[ABCD3, SLC27A2]
GO:0009620;response to fungus;5.0;0.7586651285174919;0.6695735761196662;9.089527751759436;27.267803904038782;5.926926025970411;9.126288572378991E-4;0.5933442844592942;[PTX3, ATG5]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, MAML1, CCNH, GFI1, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, IER2, ZNF282, FLT3LG, HCFC2, MED6, RUNX2, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, ZNF276, ZNF395, ZNF394, FOXG1, ZNF20, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, ZNF260, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, ZNF136, EZH2, AHCTF1, BTG2, CDKN1A, SETD3, ELL, ZNF250, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, NIPBL, ZMYM2, C1QBP, CIC, JARID2, HRAS, HAVCR2, ZNF485, TSC22D4, NCOA6, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, ZNF350, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, UBN1, ZNF101, ZNF462, EGLN2, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, RORA, YEATS4, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BAG3, TPR, ZNF549, ZNF548, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, WFS1, NONO, CAV1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, ZNF658, NFE2L3, MNAT1, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, ONECUT2, DDX41, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PEG3, RFC1, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, LCOR, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, TBX1, FBXL15, ARID3B, DEK, USF2, TNIP2, TAF7]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[OXTR, CAV1, SWAP70, GPR55, ITPR2, PKD2, P2RX7, CD4, P2RX4, GNAT2, TBXA2R, CALM3, CCL19, CALM1, CALM2, NTSR1, CCR10, CCR2]
GO:0097680;double-strand break repair via classical nonhomologous end joining;10.0;1.0;0.9152410118609203;9.628524252492122;369.5024620707547;8.67846133901236;0.012366914874882012;0.8590579283277371;[XRCC6]
GO:0042766;nucleosome mobilization;6.0;1.0;0.8231203125901445;9.628524252492122;58.07307143809032;8.390779266560578;0.0019436534386617491;0.7522251544931926;[POLE3, ARID1A]
GO:0009617;response to bacterium;5.0;0.7508913569872202;0.6656866903545304;8.935377071932177;27.267803904038782;3.9481280100702625;9.126288572378991E-4;0.49214846190264216;[ANKRD17, FGA, FCER1G, SEH1L, HIST1H2BJ, PPP1R11, CCL20, CAV1, DEFB1, IL27, RNASE3, NLRC4, WASL, LYST, VIL1, P2RX7, CD4, IL6, IL23A, BCL3, NLRP3, IL12A, HIST1H2BC, HAVCR2]
GO:0051595;response to methylglyoxal;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;30.786932525661108;9.083926447120524;0.0010304109251934586;0.7547934328124444;[SIN3A]
GO:0016266;O-glycan processing;9.0;0.7866048967936545;0.7895430735771163;9.277126365654233;178.64096908048714;5.666199763507158;0.0059789524686895724;0.6860103445912811;[GALNT12, GALNT11, ST6GAL1, GALNT10]
GO:0018206;peptidyl-methionine modification;8.0;0.7763722522362496;0.7631861261181248;9.182237149863703;154.24579517762936;7.292166977892469;0.005162467952392046;0.747921758369865;[METAP2]
GO:0006281;DNA repair;7.0;0.6281612110245125;0.6649999707694567;8.781226392104918;180.342582143442;3.582668236575797;0.006035903926554339;0.534137185486798;[USP36, DCLRE1A, FEN1, BTG2, SMG1, WDR48, DCLRE1C, CCNH, MUM1, CIB1, BRCA1, YY1, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, EP300, TOPBP1, RFC5, UPF1, AQR, RFC3, RFC4, FBXO18, DTX3L, RFC1, NCOA6, PARP2, NSMCE2, RAD23A, DDB1, NEIL3, RAD51C, MSH3, TIMELESS, PCNA, PNKP, COPS7B, COPS7A, XPC, UNG, RAD51AP1, TFPT, FZR1, WRN, POLR2B, RAD21, RAD54L, POLR2G, USP51, FANCI, POLQ, XRCC6, UBE2B, EYA2, XRCC5, INTS3, NONO, GINS4, APEX2, CDC7, FANCE, GTF2H4, SETX, CDK9, SMUG1, HIST3H2A, COPS5, RAD51, NPLOC4, TTC5, UBE2T, POLE2, CDK2, ERCC5, MNAT1]
GO:0007250;activation of NF-kappaB-inducing kinase activity;12.0;1.0;0.9481203125901445;9.628524252492122;1337.9940718610228;6.8867018697843045;0.04478145746870162;0.8003065664753022;[ZFP91, TNFRSF10B, TNFRSF10A]
GO:0006283;transcription-coupled nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;5.486614186532078;0.006172937954381027;0.676826329833192;[RFC5, AQR, RFC3, RFC4, PCNA, RFC1, CCNH, COPS7B, COPS7A, GTF2H4, DDB1, COPS5, POLR2B, EP300, POLR2G, ERCC5, MNAT1]
GO:0043105;negative regulation of GTP cyclohydrolase I activity;6.0;1.0;0.8231203125901445;9.628524252492122;49.25044374993458;9.777073627680469;0.0016483680297885973;0.8231203125901445;[GCHFR]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, CRTC2, ITGB2, CEBPG, CIB1, NLRC4, LRP8, RELA, STK3, MTDH, RPS6KA4, EP300, NLRP3, RIPK1, CYTL1, UBE2I, BUD31, SPHK1, TMEM173, PPRC1, NFKB1, IL6, COPS5, TRIM14, KRAS, TRIM32, ARHGEF5, CARD11]
GO:0007019;microtubule depolymerization;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;92.92880478075006;7.004484905440688;0.003110243465517153;0.7091290490632969;[KIF19, KIF2C, CKAP5]
GO:0045648;positive regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;358.80145150428314;6.409777797693995;0.012008761681506467;0.7027963346592216;[ARNT, NCKAP1L, SMAP1]
GO:0022400;regulation of rhodopsin mediated signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;59.729069814557675;6.641579411751319;0.0019990782140203315;0.6905700452391912;[PDE6B, CALM1, METAP2]
GO:0007259;JAK-STAT cascade;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;6.221725566191056;8.845336528452411E-4;0.6690987000520388;[IFNAR2, PKD2, CCR2]
GO:0008589;regulation of smoothened signaling pathway;6.0;0.7671156992804218;0.7066781622303554;9.0689084645567;41.8512380110395;5.500407508664414;0.0014007232725606145;0.6044114083783503;[ANKMY2, CREBBP, SFRP1, MGRN1, RFX4, IFT122, TUBD1, RORA, RUNX2]
GO:0034629;cellular protein-containing complex localization;5.0;0.7043150770688792;0.6423985503953599;8.616923340813642;38.207100950210915;6.599019797332524;0.0012787572846451128;0.6277151911823093;[SEC13, SEH1L, EXOC3, WASL, EXOC1]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[TCERG1, ZNF175, NAB1, GFI1, GMNN, ARID4A, UBP1, IKZF1, IKZF2, YY1, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZNF282, ZBTB32, HCFC2, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, XRCC5, WFS1, NONO, CAV1, H3F3A, NFKB1, CNOT7, CDK5, QARS, CNOT1, PKIA, SP3, BCL3, CDK2, ZNF658, NFE2L3, ZNF136, EZH2, CDKN1C, USP36, CIITA, BTG2, YWHAB, OTUD7B, BRCA1, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, ZNF485, TSC22D4, HELLS, KLF11, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, TFDP2, NFX1, MTF2, DEPDC1, LCOR, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, LIMS1]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[CRTC2, ZNF175, NCF1, MAML1, CCNH, GFI1, CD80, ARID4A, RORA, YEATS4, IKZF1, GPATCH3, IKZF2, ELK1, YY1, RPS6KA4, MYC, ZXDC, DPF2, TRIM24, EP300, SOX8, SOX6, IER5, ZNF564, IER2, FLT3LG, MED6, RUNX2, PIAS2, ARMCX3, ILF3, SFRP1, KARS, IL23A, TBL1XR1, CCNE1, RFX4, HOXB4, MAX, NOLC1, RLF, SUPT6H, HSPH1, RAD21, HLTF, DVL3, SCAP, NLRP3, HOXC4, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, CDKN1C, CIITA, SETD3, ONECUT2, ELL, DDX41, HOXC13, BRCA1, AATF, PKD2, WDR43, CKS1B, FLCN, NIPBL, LBH, SIN3A, NUP62, HRAS, ZNF485, SEC13, TBP, KLF13, RBM15, PEG3, DTX3L, RFC1, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, ARID1A, SIRT2, ZFP90, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, TP53INP2, TP53INP1, GPBP1L1, MTA2, E2F7, E2F8, TBX1, RNF20, ZNF462, CHURC1, NFYC, ATAD2, ARID3B, GRHL1, USF2, CD4, NFIA, NFIB, TNIP2, TTC5, NFIC, CAMK4, MARS, PSMC1, TAF7, CAMK1, MIXL1]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ENDOG, ELL, UBE2B, RIC8A, FLCN, CCNB1, FUT8, RXRA, ALS2, SIN3A, MAFF, CCM2, SOX8, EIF4E2, ATP7A, APBA3, SOX6, SEC24C]
GO:0032201;telomere maintenance via semi-conservative replication;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;216.32599304453976;6.7325511899570465;0.0072402363064467505;0.719302980950052;[RFC5, UPF1, FEN1, RFC3, RFC4, PCNA, RFC1]
GO:0001947;heart looping;7.0;1.0;0.8509193652572005;9.628524252492122;47.98143023837329;5.71663061713405;0.001605895289594654;0.6432681208679463;[TMED2, PKD2]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[PRNP, C1QBP, PDCD1LG2, HAVCR2]
GO:1904172;positive regulation of bleb assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;9.083926447120524;0.006704083591926775;0.8607930461318132;[P2RX7]
GO:0032324;molybdopterin cofactor biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;1747.0845341163006;7.8311634786251565;0.058473347082872544;0.8329150168128974;[GPHN]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[SLC12A2, KCNK6, KCND1, SLC9A6, KCNK12, KCNA3, PKD2L1, ATP1B2, KCNN3, PKD2, KCNK3, AQP1]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[CRTC2, RPL3, DGKD, NDUFA11, NCF1, CCNH, NDUFA10, GMNN, PKD2L1, IKZF1, TMEM141, IPO4, GLS, IGF1R, PSMD8, RPS15, PSMD4, TFG, PPAT, MYC, ZNF207, EP300, OIP5, KNTC1, FBXO5, TLE4, TSPYL1, COG4, BCS1L, PRKAB1, KCTD5, MED6, NUP93, COX7A2L, TBC1D20, KCTD10, PRPF3, MRTO4, SNRPG, KCTD14, CHMP4B, CD2BP2, TSPYL6, PPID, HIST1H2BC, NDUFB10, TUBGCP2, YTHDC1, EPB41, MAX, KLHL12, XPC, ACACA, DHX30, ATXN2, CCNB1, SPAST, RNF213, TSPAN4, ATP6V0A2, NLRP3, NCKAP1L, RIPK1, ECT2, S100A10, TRAPPC2, VASP, TRAPPC3, PRNP, CREBBP, XRCC6, CPSF6, TOR1A, CAV1, H3F3A, EIF2AK3, NUP153, PILRB, EIF2S1, RPL3L, SETX, VIL1, COL1A2, CNOT7, SYNJ1, ARPC2, MNAT1, AHCTF1, GPAA1, YWHAB, SRP54, CLTA, WASL, USP39, PKD2, CLYBL, PPP6C, CHAF1B, CHAF1A, SH3PXD2A, C1QBP, NUP62, TMED2, SNAP29, HRAS, RBM5, ATPAF2, FGA, SEC13, PDCD6IP, TBP, KCND1, FCER1G, ATPIF1, FGG, CKAP5, TAPBP, DDB1, GCHFR, ALDH5A1, RAD51C, NDUFS7, TRAPPC6B, NDUFS6, POLR1E, VAMP4, CHMP6, ALDOA, SLU7, ITGB3BP, MCM2, COLEC12, NDUFB7, HIST1H2BO, HIST1H2BJ, HDAC1, DDX23, ITLN1, KCNA3, NLRC4, HSD17B8, TM9SF4, NAPG, FOXRED1, HLA-DMA, RXRA, HLA-DMB, RBBP5, CCL5, UBN1, AP2S1, STX5, RBBP7, BID, POLQ, RRM1, NDUFA7, SEPT11, NUBPL, RPL23A, GTF2H4, P2RX7, CENPE, BOP1, CENPF, MARCKS, RAD51, P2RX4, CENPH, IMPDH2, CENPJ, CENPK, POLE3, CENPL, TAF7, CCDC65, ERCC5, CENPP, SEC24C]
GO:0006296;nucleotide-excision repair, DNA incision, 5'-to lesion;8.0;1.0;0.875;9.628524252492122;115.13879119899096;6.166155715036245;0.0038535917232456105;0.6903374900225189;[DDB1, RFC5, RFC3, RFC4, PCNA, RFC1, ERCC5, GTF2H4]
GO:0008593;regulation of Notch signaling pathway;6.0;0.811012628672052;0.7286266269261705;9.405380701177911;41.8512380110395;5.277263957350204;0.0014007232725606145;0.5929998367869052;[NFKBIA, GALNT11, CREBBP, MAML1, ARRDC1, SLC35C2, TSPAN17, SLC35C1, EP300, HIF1AN]
GO:0006294;nucleotide-excision repair, preincision complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;65.90281547005735;6.409777797693995;0.002205707925099542;0.6787156999164222;[DDB1, CCNH, ERCC5, XPC, MNAT1, GTF2H4]
GO:0043353;enucleate erythrocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;24.061958056348765;8.16763571524637;8.053320817896622E-4;0.7408135829017477;[SP3, CEBPG]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[HDAC1, RBBP5, SIN3A, H3F3A, EP300, CIB1, THBS1, TNRC6A]
GO:0006297;nucleotide-excision repair, DNA gap filling;7.0;1.0;0.8509193652572005;9.628524252492122;149.0421272461911;6.641579411751319;0.0049883058697239;0.6905700452391912;[RFC5, RFC3, RFC4, PCNA, RFC1]
GO:0006298;mismatch repair;8.0;0.8259837884571596;0.7879918942285797;9.500690880982237;183.0506323445446;6.375876246018314;0.006126539929698291;0.701062607729944;[PCNA, MSH3, EXO1, XPC]
GO:0042267;natural killer cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;47.356962503066434;6.7325511899570465;0.001584994916478408;0.6674232935401965;[PRDX1, CEBPG, SLAMF7, LYST]
GO:0045779;negative regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;83.00611842489866;7.292166977892469;0.002778140083024753;0.7238411236270654;[P2RX7, IL6, CSK]
GO:0075044;autophagy of host cells involved in interaction with symbiont;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.524811843842954;8.16763571524637;0.0013563289824505948;0.7408135829017477;[ATG5]
GO:0034614;cellular response to reactive oxygen species;5.0;0.7671156992804218;0.6737988615011312;9.197741336399668;144.094088465717;5.076593261888053;0.004822699464687224;0.5498582273596049;[SETX, BECN1, IL6, PCNA, NCF1, PXMP2, CDK2, ECT2, PKD2, RELA, EZH2, AQP1]
GO:0030259;lipid glycosylation;6.0;1.0;0.8231203125901445;9.628524252492122;50.53614939134546;7.474488534686424;0.0016913994405466648;0.7053660038532718;[SLC35C1]
GO:0031587;positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;14.0;1.0;0.9759193652572005;9.628524252492122;2786.515379930216;8.67846133901236;0.09326216206523613;0.9197362817240172;[PKD2]
GO:0034613;cellular protein localization;4.0;0.4527475610289664;0.4763737805144832;6.332687386487793;26.8334375525691;2.8773505203955967;8.980910063585456E-4;0.39714783942351395;[RAB3B, SYS1, RPL3, NCF1, BUB1B, ZDHHC6, ABCA12, IPO4, RPS15, IPO8, IPO9, LAMP2, LONP2, GSTK1, RPS9, RPS7, COG3, PAQR3, ARMCX3, NUP93, CHMP4B, RPL29, SLC27A2, KPNB1, ACOT4, SEH1L, FBLN5, UGT8, RAD21, RAB6A, FAM83D, S100A10, BBS2, TOR1A, PMM1, XRCC5, CAV1, RAB3IP, IFT122, NUP153, TIMM44, CDK5, GOLGB1, DCP1A, EZH2, TRAM1, ITGB2, SRP54, WASL, TRAM2, GPHN, NIPBL, SIN3A, NUP62, TMEM107, TMED2, TNPO1, TNPO2, ARL5A, RAB8B, GRIPAP1, SEC13, FCER1G, SSR2, GAK, ACOX2, AGPS, EXOC3, PIK3C3, MAPRE1, VAMP5, EXOC1, MCPH1, BECN1, ROCK2, ZDHHC23, HSD17B4, ZDHHC24, RGPD1, TM9SF4, AP3M1, WRN, LMNA, HEATR3, BID, RAE1, RPL19, PEX16, TIMM8B, UBL4A, SEPT11, TMEM30A, PEX19, AGK, RPL23A, RAB11A, TM9SF1, SPCS2, SLMAP, VPS41, TSPAN17, RAB13, TAOK2, RAB3GAP2, RAB3GAP1]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[P2RX4, ITGB2, PTX3, PKD2]
GO:0070869;heterochromatin assembly involved in chromatin silencing;7.0;0.8933024483968273;0.7975705894556142;9.4949928598676;115.3913021266095;9.777073627680469;0.0038620430367479223;0.8509193652572005;[POLE3]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[PRNP, CDK5, ITGB2, CIB1, HRAS]
GO:0006383;transcription by RNA polymerase III;10.0;0.8436909121759173;0.837086467948879;9.499312521012115;583.8786478812184;6.113511981550823;0.01954189288791682;0.7278862989048107;[GTF3C1, ZNF143, TBP, ELL, POLR3B, POLR3C, POLR3E]
GO:0000715;nucleotide-excision repair, DNA damage recognition;5.0;0.9326813400603323;0.7565816818910864;9.474373572664863;21.24116723228514;6.641579411751319;7.10922751455178E-4;0.6298916918429109;[DDB1, COPS5, COPS7B, COPS7A, XPC]
GO:0006260;DNA replication;7.0;0.7307253602413294;0.7162820453778652;9.271849308553389;254.20053156235352;4.77312732173501;0.008507863025766288;0.5950173184638491;[FEN1, PNKP, MCM10, BRCA1, POLB, CHAF1B, WRN, CHAF1A, EXO1, SIN3A, RBBP7, RFC5, UPF1, POLQ, RRM1, RFC3, DUT, RFC4, RFC1, NCOA6, DONSON, WRNIP1, CDC7, BAZ1A, CCDC88A, NFIA, NFIB, NFIC, POLE2, CDK2, POLE3, CDK2AP1, MCM5, MCM6, MCM2]
GO:0006261;DNA-dependent DNA replication;8.0;0.7586651285174919;0.754332564258746;9.318369324188282;254.89367874291247;6.250713103064308;0.008531062038107634;0.6946617587785947;[POLB, RFC5, POLQ, RFC3, RFC4, RFC1, POLE2, PNKP, DONSON, CDK2AP1, WRNIP1, BAZ1A]
GO:0009890;negative regulation of biosynthetic process;5.0;0.4064524777724522;0.49346725074714637;5.727995626489711;39.03067680567534;2.4246325274368865;0.001306321627357358;0.41423683207098605;[ERRFI1, TCERG1, ZNF175, NAB1, GFI1, GMNN, EIF4A3, ARID4A, UBP1, IKZF1, IKZF2, YY1, EIF4ENIF1, MYC, SAP130, DPF2, TRIM24, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, TIPIN, LAG3, FBXO18, IGFBP5, ZNF282, SFMBT2, ZBTB32, HCFC2, RUNX2, EID1, ILF3, SFRP1, BRMS1, ZNF93, XRN1, MSH3, TBL1XR1, PSPC1, CCNE1, DDIT4, HOXB4, TIMELESS, PPID, MAX, FOXG1, SUPT6H, MTDH, FXR1, BAG3, TPR, HIVEP1, HESX1, SCAP, SUDS3, BPTF, TFAP2A, DR1, CREBBP, XRCC6, ZNF263, UBE2I, XRCC5, WFS1, NONO, CAV1, H3F3A, EIF2AK3, CNOT10, ERLIN2, EIF2S1, NFKB1, IL6, GNL3L, STAG2, CNOT7, CDK5, QARS, CNOT1, PKIA, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, CNOT8, ZNF136, EZH2, CPEB4, CDKN1C, USP36, CIITA, BTG2, YWHAB, ITGB3, OTUD7B, NAT10, BRCA1, AATF, FLCN, NIPBL, SIN3A, C1QBP, LRRFIP1, HIF1AN, CIC, JARID2, CCR2, DACT1, ZNF485, UPF1, TSC22D4, HELLS, KLF11, KLF12, PEG3, RFC1, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, GCHFR, NCOR1, RBL1, TFDP2, NFX1, MTF2, TFEC, DEPDC1, LCOR, EIF4E2, DCP2, HBEGF, MCPH1, HDAC3, ZNF350, HDAC1, LRP8, RELA, ARNTL, BCLAF1, RXRA, RBBP7, MTA2, E2F7, ZNF189, E2F8, IRX1, YTHDF3, NFYC, DONSON, CTNS, PER2, NLRP12, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, TAF7, TNRC6A, LIMS1]
GO:0032790;ribosome disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;96.99997869907772;7.697632086000634;0.0032465019927449285;0.7167775754447168;[MRRF]
GO:0006266;DNA ligation;7.0;0.7763722522362496;0.7391054913753253;9.35659053700848;149.0421272461911;7.004484905440688;0.0049883058697239;0.7091290490632969;[POLB, XRCC6, PARP2]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[SIVA1, DIABLO, EYA2, PARP2, CD70, G0S2, TNFRSF10B, CIB1, TNFRSF10A, P2RX7, BAG3, MKNK2, CASP2, RIPK1, IL12A, BID]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, MAP3K3, UBE2I, SLC20A1, ZDHHC13, TNFRSF10B, RELA, MTDH, AKAP13, CD4, TFG, TNIP2, UBD, NUP62, RIPK1, CCL19, ECT2, TRIM32, CARD11, TMED4]
GO:0000712;resolution of meiotic recombination intermediates;5.0;1.0;0.7902410118609202;9.628524252492122;26.252913020668647;6.8867018697843045;8.786613727139965E-4;0.6424272657460779;[TOP2B]
GO:0042276;error-prone translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.7325511899570465;0.025467164394386097;0.7595439928109722;[RFC5, RFC3, RFC4, PCNA, RFC1, POLE2]
GO:0046513;ceramide biosynthetic process;8.0;0.811012628672052;0.780506314336026;9.474373572664863;443.75121156962103;6.015873511986907;0.014851953701072812;0.6826520511697386;[P2RX7, UGT8, AGK, DEGS1]
GO:0006265;DNA topological change;7.0;1.0;0.8509193652572005;9.628524252492122;171.38190676714436;7.57984905034425;0.005735998185793931;0.738553198190834;[TOP2B]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[NCKAP1, ACTR2, ARPC2, WIPF2, ARPC1A, ELMO1, NCKAP1L, WASL, VAV1]
GO:0032308;positive regulation of prostaglandin secretion;10.0;0.8933024483968273;0.861892236059334;9.548481544818586;484.66648287468473;7.474488534686424;0.016221351010299763;0.7974867031240476;[P2RX7, P2RX4]
GO:0034969;histone arginine methylation;10.0;0.8436909121759173;0.837086467948879;9.4949928598676;763.7881202265191;7.212124270218933;0.025563301019300884;0.7840693824379941;[PRMT3]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, BAG3, TPR, TFEC, HSPA6, RBBP7, SLU7, IER5, THBS1, EIF2S1]
GO:0016071;mRNA metabolic process;7.0;0.5916390046238794;0.6467388675691402;8.385330735012905;115.0816327851482;3.2924383920452174;0.0038516786825735262;0.5192948177404362;[HBS1L, SMG1, AHCYL1, RPL3, RNH1, CCNH, EIF4A3, DDX42, DDX41, CASC3, USP39, SMG5, EFTUD2, RPS15, UBL5, ALKBH5, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, UPF2, UPF1, AQR, RPS9, RBM15, RPS7, BUD31, PUS1, SSU72, ARNT, TFIP11, THOC2, SRRM1, THOC6, ERN1, XRN1, PSPC1, PRPF3, MRTO4, FASTKD5, SNRPG, CD2BP2, ETF1, RPL29, SLU7, DCP2, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, CEBPG, SUPT6H, PPP2CA, PABPN1, U2AF2, POLR2B, SNRPB2, POLR2G, EXOSC3, SMNDC1, DCPS, RPL19, CPSF6, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, CNOT10, RPL23A, LSM5, GTF2H4, CNOT4, CNOT6, PAN3, TFCP2, SON, CNOT7, CNOT1, CNOT3, ACIN1, SKIV2L, CNOT8, DCP1A, MNAT1, GRSF1]
GO:0045794;negative regulation of cell volume;7.0;1.0;0.8509193652572005;9.628524252492122;50.63290440139966;8.16763571524637;0.001694637743659323;0.7686126355688037;[P2RX7, CLCN3]
GO:0043132;NAD transport;7.0;0.8933024483968273;0.7975705894556142;9.541512875502493;66.46454672723188;9.083926447120524;0.002224508564751864;0.8154717862087246;[P2RX7]
GO:0031573;intra-S DNA damage checkpoint;10.0;1.0;0.9152410118609203;9.628524252492122;277.3883443919017;7.069023426578259;0.009283938253494562;0.7767511986393403;[TIPIN, XPC]
GO:0016079;synaptic vesicle exocytosis;9.0;0.8436909121759173;0.8180860812682478;9.510741216835738;175.934860638427;5.885253329569843;0.0058883814544733026;0.6972127541467594;[RPH3A, P2RX7, TRIM9, CDK5, SYT15, SYTL3]
GO:0010510;regulation of acetyl-CoA biosynthetic process from pyruvate;8.0;1.0;0.875;9.628524252492122;198.41229450693845;7.697632086000634;0.0066406809376752364;0.7686572628545723;[PDPR]
GO:0033633;negative regulation of cell-cell adhesion mediated by integrin;7.0;1.0;0.8509193652572005;9.628524252492122;131.62994541426704;9.777073627680469;0.004405535813755672;0.8509193652572005;[SWAP70]
GO:0070987;error-free translesion synthesis;10.0;1.0;0.9152410118609203;9.628524252492122;760.9157207671086;6.781341354126479;0.025467164394386097;0.7620391240755716;[RFC5, RFC3, NPLOC4, RFC4, PCNA, RFC1]
GO:0000723;telomere maintenance;7.0;0.7307253602413294;0.7162820453778652;9.292052015870908;183.01793442924338;5.266214121163619;0.006125445559899373;0.6202338003175094;[RFC5, UPF1, DCLRE1A, FEN1, RFC3, XRCC6, DCLRE1C, RFC4, PCNA, RFC1, XRCC5, NSMCE2, TFIP11, SMG5, WRN, RAD51C, RAD51, CCNE2, CCNE1, ZNF365]
GO:0007004;telomere maintenance via telomerase;9.0;1.0;0.896240625180289;9.628524252492122;760.4775577437022;6.686031174322154;0.025452499472313803;0.7381645703673706;[RFC1, SMG5]
GO:0006396;RNA processing;7.0;0.49247393176386933;0.5971563311391352;7.484544189674715;115.0816327851482;3.0330144413691222;0.0038516786825735262;0.5060278648384131;[AHCYL1, CCNH, POP4, INTS10, EIF4A3, DDX42, NAT10, DDX41, CASC3, USP39, WDR43, RRP9, EFTUD2, RPS15, RBM3, UBL5, ALKBH5, ZC3H7A, PCF11, C1QBP, ARL6IP4, SNIP1, DHX16, ZNF326, SEPHS1, RBM5, AQR, RPS9, WDR37, RBM15, RPS7, BUD31, PUS1, SSU72, IMP4, TFIP11, THOC2, SRRM1, THOC6, ERN1, KARS, PSPC1, PRPF3, RPL7L1, MRTO4, FASTKD5, SNRPG, RPP21, CD2BP2, SLU7, RBMS2, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, NOLC1, SUPT6H, PPP2CA, DHX30, PABPN1, U2AF2, POLR2B, SNRPB2, POLR2G, EXOSC3, SMNDC1, DCPS, CPSF6, PRPF38A, GPKOW, WTAP, INTS3, CPSF3, NONO, CPSF2, ADAT1, LSM5, GTF2H4, BYSL, SETX, BOP1, PAN3, SON, LAS1L, INTS4, ACIN1, INTS7, MNAT1, GRSF1]
GO:0006275;regulation of DNA replication;7.0;0.6144040707577935;0.6581214006360973;8.623002386890024;150.73814970462044;5.142344639450834;0.005045070215086414;0.6138991092621975;[ANKRD17, RFC5, TIPIN, RFC3, USP37, RFC4, PCNA, FBXO18, GMNN, DONSON, WRNIP1, CDC7, SENP2, PPP2CA, CCDC88A, STAG2, MSH3, CDK2, TIMELESS, HRAS, E2F7, ZNF365, E2F8]
GO:0043382;positive regulation of memory T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1160.4929435196905;7.9853141584524145;0.038840654443761495;0.8236103492792612;[IL23A, IL12RB1]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[CDKN1C, ERRFI1, CDKN1A, HDAC3, CIB1, PTPN22, DUSP14, IGF1R, PPP2CA, FLCN, CCNB1, HSPH1, NNT, SNX25, MYC, NUP62, STK38, PBK, CSK, DACT1, DUSP5, PRNP, CDKN2C, UBE2B, AMBP, CAV1, PAQR3, SIRT2, DUSP22, P2RX7, ITCH, NLRP12, SFRP1, NCOR1, CDK6, QARS, CTDSP2, GNAQ, PKIA, DDIT4, TAF7, CALM3, CRIPAK, CALM1, EPHA1, CHMP6, CALM2, PAFAH1B1]
GO:0018243;protein O-linked glycosylation via threonine;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;335.8824965316705;7.8311634786251565;0.011241684884293463;0.7967266896635242;[GALNT11]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[GYPA, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, CD99L2, LYST, CORO1A, GLG1, CCL5, NCKAP1L, CCL19, CCR2, HSD3B7, FCER1G, CCL20, CAV1, TNFRSF10B, TNFRSF10A, ATP1B2, VAV1, NLRP12, IL6, COL1A2, SDC1, CD244, ARHGEF5]
GO:0010524;positive regulation of calcium ion transport into cytosol;12.0;0.811012628672052;0.8536266269261705;9.4949928598676;446.85811756486936;5.825829909099042;0.01495593904869991;0.7460535250702665;[P2RX7, CD4, P2RX4, CAV1, CALM3, CALM1, PKD2, CALM2, NTSR1]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, PRNP, CDKN1A, CDKN2C, PKD2, THBS1, PRKAB1, PPM1G, ERN1, CDK6, FAP, MYC, TP53INP1, IL12A, PRR11, HRAS, EIF4G2, MCPH1]
GO:1903285;positive regulation of hydrogen peroxide catabolic process;8.0;1.0;0.875;9.628524252492122;565.2094731881521;9.083926447120524;0.01891705241210629;0.839552420951524;[NNT]
GO:0007051;spindle organization;6.0;0.6873818243518346;0.6668112247660618;8.690254613899192;44.522636097919765;4.786641040901733;0.0014901325624263064;0.5679093580234316;[HDAC3, TUBGCP2, TUBG1, CKAP5, NDC80, RAB11A, CENPE, CCNB1, SPAST, NCOR1, ESPL1, KIF4A, TBCE, NUF2, ZNF207, FBXO5, MAPRE1, KPNB1, CLASP1, SPC25]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[RPS9, YTHDF3, POLDIP3, ITGA2, EIF4A3, THBS1, FXR1, RBM3, IL6, RXRA, C1QBP, CCL5, BCL3, POLR2G]
GO:0061098;positive regulation of protein tyrosine kinase activity;11.0;0.8436909121759173;0.8542744084176208;9.55953138100517;2154.6219316186807;5.8650506222523235;0.07211325701743153;0.7323679139043926;[PRNP, HSPH1, NCF1, CCL5, LRP8]
GO:0046931;pore complex assembly;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;40.42272244673708;7.004484905440688;0.0013529121422039536;0.6484506956670166;[NUP93, P2RX7, AHCTF1, NUP153]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[RRM1, SEPT11, XRCC6, CPSF6, YWHAB, IKZF1, HSD17B8, PRKAB1, GCHFR, COL1A2, NUP62, RIPK1, HRAS, S100A10]
GO:0051292;nuclear pore complex assembly;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;123.37008173774021;7.474488534686424;0.004129085609897011;0.7053660038532718;[NUP93, AHCTF1, NUP153]
GO:0045724;positive regulation of cilium assembly;9.0;0.8933024483968273;0.8428918493787028;9.537552474286395;366.9725033529874;6.7325511899570465;0.012282239433413365;0.740543606130341;[CCDC88A, CENPJ]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[RRM1, XRCC6, CPSF6, HSD17B8, S100A10]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ERRFI1, RABGAP1, DOCK8, RASGRP2, RIC8A, ABR, DOCK11, ARHGAP21, RGS1, CCL5, ARHGDIB, DVL3, NCKAP1L, EVI5L, CCL19, ECT2, A2M, TBC1D22A, HRAS, S100A10, STARD13, SEC13, CCL20, TBC1D8, TBC1D2B, ARHGAP25, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, GNAQ, RUNDC1, DEPDC1, RAB3GAP2, PKP4, TAX1BP3, ARHGEF1, DOCK2, EPHA1, SMAP1, ARHGEF5, RAB3GAP1, EZH2, LIMS1]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, RXRA, ALDH5A1, IMPDH2, PPAT, ATPIF1, ALDOA, PKD2, ACACA, GLS]
GO:0051168;nuclear export;7.0;0.6729672293956388;0.6874029799550199;8.529911963824013;33.8974465615721;4.665085839323926;0.001134517030694512;0.5894920720289035;[SMG1, AHCYL1, SEH1L, POLDIP3, EIF4A3, CASC3, SMG5, RPS15, AKAP13, ALKBH5, NXF3, PABPN1, U2AF2, TPR, NUP62, XPO5, NUP43, RAE1, UPF2, UPF1, CPSF3, CPSF2, NUP153, THOC2, SRRM1, THOC6, NUP93, LSG1, SLU7]
GO:0031397;negative regulation of protein ubiquitination;10.0;0.7508913569872202;0.7906866903545304;9.372590878354922;529.4632463014641;5.572381008289503;0.01772065836772442;0.7002128357670632;[DTX3L, RPS7, CAV1, GLMN, PRMT3, SENP2, PER2, GNL3L, CDK5, U2AF2, FBXO5, MAD2L1, ATG5]
GO:0045739;positive regulation of DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.360260265897443;499.6181899148078;5.8650506222523235;0.01672177118926996;0.6749389615747303;[PCNA, DTX3L, EYA2, CEBPG, TIMELESS, BRCA1]
GO:0035871;protein K11-linked deubiquitination;10.0;1.0;0.9152410118609203;9.628524252492122;204.99431233642397;7.474488534686424;0.006860975150996652;0.7974867031240476;[VCPIP1, USP37, OTUD7B]
GO:0070914;UV-damage excision repair;8.0;1.0;0.875;9.628524252492122;251.03601357316452;7.292166977892469;0.008401949456549422;0.747921758369865;[DDB1, HIST3H2A, XPC]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[CMTM7, DOCK11, DCLRE1C, SP3, BCL3, CEBPG, EP300, CARD11]
GO:0033572;transferrin transport;10.0;1.0;0.9152410118609203;9.628524252492122;96.80640656383476;6.193554689224359;0.0032400233075819585;0.731979686697602;[TFRC, ATP6V0A2, ATP6V1F]
GO:0008033;tRNA processing;9.0;0.6007507099811141;0.6966159801708461;8.495425787752843;356.94625997820395;4.973052582947213;0.011946670090692574;0.6505627655428052;[KARS, POP4, PUS1, RPP21, ADAT1, NAT10, SEPHS1, GRSF1]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[CREBBP, XRCC6, POLR3B, POLR3C, XRCC5, EP300, PTPN22, DDX41, LRRFIP1, TMEM173, NFKB1, RELA]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, SIGLEC9, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CTSH, GUSB, SNAP29, ACTR2, SERPINB1, FCER1G, PLAUR, COMMD3, RNASE3, TMEM173, UNC13D, SERPINB6, VAMP8, ACLY, DOCK2, ALDOA, SLC27A2, KPNB1, CSTB, PDXK, CLEC12A, UBR4, IQGAP2, C3, RAP1B, COMMD9, PSMB1, NCKAP1L, RAB6A, XRCC6, TMEM30A, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[PRNP, WFS1, GFI1, CEBPG, PKD2, NFKBIA, ITCH, NLRP12, BRMS1, ADORA3, NLRP3, EZH2, HAVCR2]
GO:0006099;tricarboxylic acid cycle;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;83.50034911327728;6.250713103064308;0.0027946815393860435;0.6946617587785947;[CS, NNT, IDH2, IDH3B, SUCLG1, ACO1, ACO2]
GO:0000422;autophagy of mitochondrion;6.0;0.8653626801206646;0.7558016526504768;9.446202695698167;99.5332381578633;6.015873511986907;0.003331287907044985;0.6307723637598831;[BECN1, GABARAPL1, FUNDC1, MARK2, ATG5]
GO:0097062;dendritic spine maintenance;7.0;1.0;0.8509193652572005;9.628524252492122;53.70815772734724;7.474488534686424;0.0017975637049304797;0.7331650565203278;[PRNP, IGF1R]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[GPAM, IL23A, IL12RB1]
GO:0009249;protein lipoylation;9.0;1.0;0.896240625180289;9.628524252492122;361.1597003547901;7.697632086000634;0.012087690148246762;0.7898978880348613;[LIAS]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[NFKBIA, KARS, CD70, TNFRSF10B, RIPK1, TNFRSF10A, RELA, LIMS1]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[CDKN1A, NCF1, CCNH, ITGB3, KIF14, CIB1, PKD2, CKS1B, AKAP13, NEK1, HRAS, PDGFRB, DUSP5, ZFP91, OXSR1, MAPK8IP3, ERN1, KARS, ALS2, IL23A, JTB, MTCP1, LCP2, ADNP, ARHGEF5, LRP8, THBS1, STK3, PPP2CA, CCNB1, HSPH1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, CCL19, ECT2, MARK2, MAP3K3, PRNP, XRCC6, PDE6H, XRCC5, TNFRSF10B, TNFRSF10A, PILRB, P2RX7, CENPE, CCDC88A, CD4, CDK5, TAOK2, KRAS, CALM3, CAMK1, CALM1, MNAT1, CALM2, EZH2]
GO:0032233;positive regulation of actin filament bundle assembly;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;256.92976895603965;5.734022359845919;0.008599208145178776;0.7084791820027498;[VIL1, SFRP1, SWAP70, EPHA1, ARHGEF5, S100A10]
GO:2000601;positive regulation of Arp2/3 complex-mediated actin nucleation;13.0;1.0;0.9625549647676366;9.628524252492122;774.2616619260014;7.8311634786251565;0.025913841034406984;0.8630410292508717;[NCKAP1, WASL]
GO:0070911;global genome nucleotide-excision repair;9.0;1.0;0.896240625180289;9.628524252492122;184.43692670566384;6.518977089658987;0.006172937954381027;0.7296214167088868;[DDB1, XPC, GTF2H4]
GO:1903292;protein localization to Golgi membrane;7.0;1.0;0.8509193652572005;9.628524252492122;65.5985109049745;8.67846133901236;0.002195523125162548;0.7947362817240173;[ARL5A]
GO:0015910;peroxisomal long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;9.083926447120524;0.0025111172729558144;0.8969813732811862;[ABCD3]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[VAMP8, VPS18, ITCH, GYPA, TFRC, SIVA1, ITGB3, ITGA2, CD80, NUP153, NCAM1]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[TBCCD1, WDR1, EPB41, WIPF2, LST1, ITGB2, CDC7, VRK1, VRK2, WASL, CORO1A, VIL1, MKLN1, CFDP1, FES, TAOK2, ALDOA, CSNK1G2, CSNK1G1]
GO:0030050;vesicle transport along actin filament;7.0;0.9326813400603323;0.8172600352873667;9.574457031221845;136.86115064074093;7.697632086000634;0.004580619544906703;0.7445766281117727;[WASL, FNBP1L]
GO:0007035;vacuolar acidification;12.0;0.9326813400603323;0.9144609826203107;9.57973408832269;182.53781204849716;6.686031174322154;0.006109376295897887;0.7900442577772261;[CLN3, ATP6V0A2]
GO:0044774;mitotic DNA integrity checkpoint;8.0;0.8259837884571596;0.7879918942285797;9.405380701177911;188.74061193661657;5.769740442447999;0.006316978425995768;0.6700647945471605;[FANCI, TOP2B, TIPIN, TAOK2, CDK2, DONSON, XPC, TOPBP1]
GO:0045746;negative regulation of Notch signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;188.1075192762445;6.193554689224359;0.006295789384399518;0.6676580400938822;[NFKBIA, ARRDC1, SLC35C1, HIF1AN]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PRKCSH, SERPINA10, CCNF, MSLN, PSMD8, PSMD7, PSMD4, PSMD2, SKP2, FGA, IGFBP5, FGG, DDB1, PSMA1, PSME2, ITIH2, COPS7B, NEDD8, COPS7A, PSMB10, PSMA7, HSP90B1, C3, TGOLN2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, KLHL25, WFS1, FEM1B, RHBDD1, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, RAB13, STT3A, CALU, FBXL3, ASB3, KBTBD8]
GO:0046834;lipid phosphorylation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;69.34085176665127;4.948759890378168;0.0023207759059147553;0.5762001235249539;[PDGFRB, SMG1, DGKD, SPHK2, AGK, DGKA, SPHK1, CD80, ZFYVE21, VAV1, IMPAD1, PIK3C3, MET, HBEGF]
GO:2000619;negative regulation of histone H4-K16 acetylation;13.0;1.0;0.9625549647676366;9.628524252492122;1675.3938874144621;8.67846133901236;0.056073925655155225;0.9063718812344532;[ATG5]
GO:0001845;phagolysosome assembly;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;81.92137458931388;8.16763571524637;0.002741834683053802;0.7686126355688037;[P2RX7, MYO7A, CORO1A]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CREBBP, CDKN1A, PCNA, RHBDD1, XPC, EIF2S1, CDC25A, AQP1, YY1, DDB1, HIST3H2A, MYC, TP53INP1, PBK, EP300, PPID]
GO:0033674;positive regulation of kinase activity;9.0;0.6073376606709605;0.6999094555157693;8.620883742029738;265.89784403492143;3.4106031799490317;0.008899361547325376;0.5706590304121504;[CDKN1A, NCF1, CCNH, ITGB3, KIF14, CIB1, PKD2, IGF1R, CKS1B, AKAP13, NEK1, HRAS, PDGFRB, DUSP5, ZFP91, OXSR1, MAPK8IP3, ERN1, KARS, ALS2, IL23A, JTB, MTCP1, LCP2, ADNP, EPHA1, MET, ARHGEF5, VAC14, LRP8, THBS1, STK3, PPP2CA, CCNB1, HSPH1, CCL5, DVL3, NCKAP1L, RIPK1, CSK, ZNF622, CCL19, ECT2, MARK2, MAP3K3, PRNP, XRCC6, PDE6H, XRCC5, RYK, TNFRSF10B, TNFRSF10A, PILRB, P2RX7, CENPE, CCDC88A, CD4, CDK5, TAOK2, KRAS, CALM3, CAMK1, CALM1, MNAT1, CALM2, EZH2]
GO:0034641;cellular nitrogen compound metabolic process;3.0;0.2577557873675379;0.3269982062739135;4.233988028203543;26.702444845077565;1.2540971915085046;8.937067983245867E-4;0.262254901285373;[ZNF175, RPL3, RNH1, MAML1, POP4, GPATCH3, ELK1, RRP9, ALKBH5, MYC, ZXDC, IER5, IER2, EARS2, GSTK1, SAP30BP, ACOT7, ENDOG, CSNK2A1, ZNF282, RNASE3, AARSD1, SND1, MED6, EID1, MTHFD1, EWSR1, RFX4, HOXB4, RPL29, ZNF276, ZNF395, ZNF394, TARSL2, ZNF20, CDCA7, NOLC1, COPS7B, COPS7A, XPC, ZNF25, PRPSAP1, UGT8, RAD21, HESX1, HOXC4, ZNF264, ZNF143, CREBBP, ZNF263, PRPF38A, PMM1, ZNF260, PBX3, LNPEP, CDC7, ZNF35, FLI1, RPL3L, SOX30, SETX, UCK2, NPLOC4, LAS1L, QARS, ZNF30, ZNF136, EZH2, CPEB4, PHF3, SETD5, BTG2, CDKN1A, SMG1, WDR48, SETD3, ELL, ZNF250, ATF7IP2, ADK, HOXC13, ZNF45, SMG5, WDR43, UBL5, NIPBL, CHAF1B, CHAF1A, RARS, CIC, JARID2, ZNF365, UPF2, ZNF485, UPF1, HELLS, DFFA, TPI1, WDR37, SPHK2, SPHK1, ATPIF1, BAZ1A, MED29, SIRT2, MED28, DDB1, NCOR2, GCHFR, NCOR1, MED20, TRUB2, SF3B5, SF3B2, ZNF350, ZNF69, UNG, EXTL2, BCLAF1, WRN, RPL19, ZNF101, ZNF462, AGK, ATAD2, ADAT1, APEX2, NMNAT3, GTF2H4, AGMAT, BYSL, CENPF, NFIA, NFIB, NFIC, RPL22L1, ZNF696, MIXL1, ZNF212, ZNF331, NAB1, MUM1, UBP1, RORA, YEATS4, CASC3, ALDH1L2, YY1, NPEPPS, LAMP2, ZNF326, ZNF688, NUDT15, ZNF564, GTF2I, TLE4, ZNF441, RPS9, ZNF680, FBXO18, RPS7, SWAP70, ZBTB32, THOC2, PIAS2, THOC6, ACLY, ILF3, MSH3, MRTO4, SNRPG, ADNP, KPNB1, ZNF550, MAX, RLF, GTF2E2, RAD51AP1, ATXN2, ZNF549, ZNF548, ZNF544, TRAPPC2, FANCI, ZBTB17, DR1, AMBP, LSM5, FANCE, NFKB1, CDK9, CNOT4, CNOT6, IRAK1BP1, TFCP2, SON, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, TPP1, CNOT8, TMEM18, MNAT1, ZNF532, ZNF410, NFE2L1, MOXD1, CIITA, ONECUT2, ADPGK, AMD1, MCM10, LBH, EXO1, SIN3A, ZNF407, ZNF768, PGM3, ZNF525, ZNF524, ZNF766, HIF1AN, ATP7A, RFC5, RFC3, REXO1, RFC4, DTX3L, RFC1, ARNT, RAD23A, TFIP11, BPGM, COASY, ZFP90, TFDP1, ZNF519, TFDP2, PCCA, IMPAD1, LCOR, POLR1E, ETF1, MCM5, MCM6, ZNF630, MCM2, PRPS2, GTF3C1, BECN1, SMARCD2, HDAC3, HDAC1, WBP2, WBP4, CEBPG, SRM, FZR1, U2AF2, POLR2B, RBBP5, TP53INP2, TP53INP1, SNRPB2, POLR2G, ASCC3, RBBP7, SEC11A, E2F7, E2F8, SEC11C, TBX1, POLR2J3, NDUFA7, DUT, GPKOW, TXNRD1, DONSON, CTNS, RPL23A, P2RX7, RAD51, POLR3B, POLR3C, PSAT1, IMPDH2, POLR3E, MNDA, MMACHC, SLC23A2, TCERG1, AHCYL1, CCNH, GFI1, EIF4A3, IKZF1, IKZF2, NADSYN1, GBA2, NUDT3, UBE2L3, AQP1, RPS15, RPL36AL, PPAT, SAP130, DPF2, TRIM24, ARL6IP4, SOX8, CHAC2, SOX6, SEPHS1, AQR, TIPIN, NSMCE2, MRPS18B, MRPS18A, IMP4, RUNX2, SRRM1, NEIL3, KARS, XRN1, MTHFD2L, CD2BP2, SUCLG1, ALDH7A1, SLC35D1, FOXG1, ATP5J, ATP5I, ATP5O, RPAP1, LIAS, ATP5L, DHX30, SGPL1, COMMD9, HLTF, HIVEP1, ATP6V0A2, HIVEP2, RPL39L, XBP1, XRCC6, APOBEC3F, SETDB1, APOBEC3H, XRCC5, INTS3, EAF2, CCDC88A, STAG1, INTS4, INTS7, DCP1A, APOBEC3A, HBS1L, TOP2B, FEN1, FASTKD1, INTS10, NAT10, BRCA1, WASL, ZMYM2, SCML1, PCF11, NNT, C1QBP, XPO5, CTSH, DHX16, TSC22D4, MRPS24, NCOA6, PARP2, COMMD3, PPRC1, ZFX, NME1, UGDH, ALDH5A1, RAD51C, NFX1, TFEC, FASTKD5, DEPDC1, ALDOA, SLU7, MRRF, DCP2, VGLL4, PCNA, MRPS36, ZNF2, COX5B, RELA, ARNTL, PPP2CA, SERTAD3, RXRA, MTHFD1L, SERTAD2, RAD54L, GPBP1L1, EXOSC3, DCPS, NFYC, GINS3, GINS4, GRHL1, PER2, PDCL3, BOP1, GFI1B, SPCS2, HIST3H2A, GSTA5, TTC5, MARS, TJP2, DCLRE1A, CRTC2, DCLRE1C, ARID4A, CPOX, CIB1, EFTUD2, NARS, NPPA, NARS2, EP300, SNIP1, PUS1, SSU72, WRNIP1, ERN1, BRMS1, ZNF93, CCNE2, TBL1XR1, PSPC1, CCNE1, PRPF3, RPL7L1, RPP21, TIMELESS, CARD11, SUPT6H, FUT8, NLRP3, USP51, CYC1, SUDS3, BPTF, TFAP2A, CPSF6, UBE2B, CPSF3, NONO, CPSF2, IDH2, CNOT10, PAN3, UBE2T, DEGS1, SKIV2L, GRSF1, ZSCAN2, PHF19, USP36, PHTF2, DDX42, DDX41, USP39, CHD1, AFF4, GPHN, POLB, GMPPB, RBM3, HK3, ZC3H7A, NUP62, LRRFIP1, TOPBP1, RBM5, KLF11, DDX59, KLF12, TBP, ABCC2, KLF13, RBM15, BUD31, CAD, MKL1, DARS2, SAFB, ARID1A, ATP5F1, TAPBP, CREB3, RBL1, ELF4, IRF4, THOP1, ITGB3BP, RBMS2, PDXK, POLDIP3, PNKP, DDX23, RRBP1, TFPT, CLN3, PABPN1, FAM120B, TAF1A, PDE6B, MTA2, SMNDC1, ZNF189, POLQ, RRM1, CHURC1, WTAP, EYA2, ARID3B, DEK, USF2, POLE4, RPIA, SMUG1, GALC, XPNPEP1, TNIP2, POLE2, POLE3, TAF7, CDK2AP1, ACIN1, ERCC5, TAF5]
GO:0035973;aggrephagy;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;41.777574812335935;7.9853141584524145;0.001398257831592581;0.7592887026755414;[UBQLN1, ATG5]
GO:0034767;positive regulation of ion transmembrane transport;7.0;0.573209793587309;0.637524262050855;7.893923197104016;131.85524397946187;4.879233827729558;0.0044130763539771975;0.6004436101148675;[P2RX7, GAL, NPPA, CALM3, ATP1B2, CALM1, PKD2, CALM2, NTSR1]
GO:1903076;regulation of protein localization to plasma membrane;7.0;0.7307253602413294;0.7162820453778652;9.117698628726131;62.75471671371763;5.346256828837156;0.0021003438928297916;0.6243271881103005;[VIL1, VAMP8, PRNP, CDK5, PPFIA1, CIB1, CSK, RAB11A]
GO:0045638;negative regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;279.0827475916144;5.4730085344763;0.00934064840372507;0.6308092762312435;[NFKBIA, ITPKB, SFRP1, KLF13, CDK6, RBM15, MYC, GPR55, CIB1, LILRB3, C1QC, NME1]
GO:0090521;glomerular visceral epithelial cell migration;7.0;1.0;0.8509193652572005;9.628524252492122;24.971868181253015;8.390779266560578;8.357859548042604E-4;0.7800242071602487;[NUP93]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[VIL1, PRNP, CIB1, RAB11A]
GO:0030163;protein catabolic process;5.0;0.6347111282356054;0.607596575978723;8.35223078658656;135.66522553384723;3.7109655375767217;0.004540593007841691;0.48001996203013964;[CCNF, KIF14, CLTA, BUB1B, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, LAMP2, TRIM24, SKP2, CTSE, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CLN3, CCNB1, FZR1, PSMB5, PSMB1, UBQLN1, AP2S1, RIPK1, RFFL, UBE2I, TOR1A, SDF2L1, LRRC29, UBE2B, KLHL25, AMBP, WFS1, EDEM1, RHBDD1, SYVN1, FBXL15, LNPEP, ERLIN2, FBXL16, BTBD6, PGA3, PGA5, P2RX7, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, FBXL3, TPP1, MAD2L1]
GO:0009107;lipoate biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;775.4730358427768;9.777073627680469;0.025954384629235713;0.896240625180289;[LIAS]
GO:0045880;positive regulation of smoothened signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;187.6437959822434;6.343086423195323;0.006280268983073171;0.6753050999230941;[SFRP1, TUBD1]
GO:0031365;N-terminal protein amino acid modification;7.0;0.5945822691631375;0.6482104998387692;8.20944006854924;151.15475272427284;6.518977089658987;0.005059013543235805;0.6843001567857983;[CREBBP, EP300, METAP2]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[CCDC88A]
GO:0002827;positive regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;171.8650643746189;6.943860283624253;0.005752169036102488;0.7301093378270707;[IL23A, CD80, CCL19, IL12RB1, CCR2]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC12A2, SLC9A6, SLC20A1, PKD2L1, ATP1B2, PKD2]
GO:0031122;cytoplasmic microtubule organization;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;50.45034613020222;5.734022359845919;0.0016885276826141221;0.6163584827319739;[CCDC88A, SPAST, KIF19, TUBGCP2, CIB1, TUBG1, KPNB1, CLASP1, RAB11A, PAFAH1B1]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[CCNH, CIB1, PKD2, THBS1, STK3, CKS1B, PPP2CA, AKAP13, CCNB1, DVL3, RIPK1, CSK, CCL19, HRAS, PDGFRB, MAP3K3, DUSP5, PDE6H, MAPK8IP3, ERN1, P2RX7, KARS, ALS2, TAOK2, MTCP1, KRAS, CALM3, CAMK1, CALM1, MNAT1, CALM2, ARHGEF5, EZH2]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[RAP1B, CFL1, PSME2, IL12A, LCP1, IL12RB1]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[FES, NUP62, BRCA1, CKAP5]
GO:0050717;positive regulation of interleukin-1 alpha secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;8.390779266560578;0.033429496098039586;0.8615337942327104;[P2RX7]
GO:0050718;positive regulation of interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;998.8167007681584;6.518977089658987;0.033429496098039586;0.7658097438582601;[P2RX7, NLRP12, NLRP7, NLRP3, CCL19]
GO:0000338;protein deneddylation;9.0;1.0;0.896240625180289;9.628524252492122;202.59641706362558;7.474488534686424;0.0067807197541817285;0.7784863164434164;[COPS5, TOR1A, COPS7B, COPS7A]
GO:0022008;neurogenesis;4.0;0.8653626801206646;0.6826813400603323;9.292052015870908;21.066225782797595;5.572381008289503;7.050676185779127E-4;0.5349718239061428;[CDK6, RYK, THOC2, BTBD6, TRAK1, DAGLB, CIT]
GO:1902951;negative regulation of dendritic spine maintenance;8.0;1.0;0.875;9.628524252492122;176.1829454725938;8.67846133901236;0.005896684630611009;0.8188169164668168;[PRNP]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, ITPR2, RORA, THBS1, AQP3, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, MYC, FUNDC1, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, ARNT, SIRT2, SFRP1, TBL2, DDIT4, HYOU1, KCNK3]
GO:0061739;protein lipidation involved in autophagosome assembly;10.0;1.0;0.9152410118609203;9.628524252492122;308.1956094800002;8.390779266560578;0.010315029691254684;0.8443458537639685;[ATG5]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[RFC5, POLQ, RFC3, RFC4, PCNA, RFC1, WRNIP1, SMG5, POLE4, POLB, CENPF, WRN, NPLOC4, POLE2, POLE3]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[P2RX7, IL6, SEH1L, HIST1H2BJ, PPP1R11, NLRP3, DEFB1, IL12A, RNASE3, HIST1H2BC, HAVCR2]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[BCAR3, IL6, CAV1, MTCP1, CAMK1, GFRA2]
GO:1901990;regulation of mitotic cell cycle phase transition;7.0;0.6144040707577935;0.6581214006360973;8.152617732682543;36.34719157774778;3.91914047319701;0.0012165077917585339;0.551344391315166;[BTG2, CDKN1A, KIF14, BUB1B, BRCA1, PKD2, GPR132, SIN3A, CDC26, ZNF207, CASP2, EP300, KNTC1, TOPBP1, GTSE1, DACT1, NSMCE2, SENP2, TUBG1, CKAP5, SIRT2, CDC25A, DDB1, RINT1, RAD51C, TFDP1, RBL1, ESPL1, TFDP2, CTDSP2, PSME2, ANAPC5, MAPRE1, PAFAH1B1, ANKRD17, PCNA, DCTN3, XPC, ANAPC11, CCNB1, UBD, RAD21, TPR, CEP70, BID, CLASP1, E2F7, E2F8, FANCI, CDKN2C, DONSON, MAD2L1BP, CNOT10, CDC7, NDC80, RAB11A, CNOT4, CENPE, CNOT6, CENPF, CDK6, CNOT7, CNOT1, PKIA, CENPJ, CNOT3, TAOK2, CDK2, CNOT8, EZH2, MAD2L1]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[SLC36A1, SLC25A3, COX4I1, ATP5J, ATP5I, COX5B, ATP5O, COX6A1, CLCN3, ATP5F1, ATP5L, COX7A2L, SLC9A6, NDUFS7, NNT, ATP6V0A2, CYC1, ATP6V1F]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, HDAC3, TUBGCP2, TUBD1, CIB1, TUBA1C, CCNB1, TUBA1B, SPAST, KIF19, NUF2, LMNA, ZNF207, FBXO5, NEFH, CLASP1, MARK2, BBS2, UBE2B, TUBG1, CKAP5, IQCG, NDC80, RAB11A, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, NCOR1, ESPL1, CDK5, FES, KIF4A, CENPJ, TBCE, KIF2C, KIF20A, VAMP4, CALM1, MAPRE1, KPNB1, PAFAH1B1, SPC25, MCPH1]
GO:0060754;positive regulation of mast cell chemotaxis;10.0;1.0;0.9152410118609203;9.628524252492122;508.7364383666408;7.9853141584524145;0.01702695075906198;0.8236103492792612;[SWAP70]
GO:0060997;dendritic spine morphogenesis;8.0;1.0;0.875;9.628524252492122;122.19110678714402;6.8867018697843045;0.004089626379309125;0.7271862538851576;[WASL, ZNF365]
GO:0046474;glycerophospholipid biosynthetic process;7.0;0.6634067003016617;0.6826227154080313;8.822899088505487;510.210298105942;4.383446081328108;0.01707627951814874;0.5750890017074093;[ARF3, AGPAT5, VAC14, PLA2G12A, PLEKHA2, AGK, DGKA, STARD10, CRLS1, RUFY1, DPM3, SYNJ1, FABP5, GPAM, PIK3C3]
GO:0070317;negative regulation of G0 to G1 transition;7.0;1.0;0.8509193652572005;9.628524252492122;83.03241800612349;6.139487467954083;0.002779020306340262;0.6648930398837374;[RAD51, TFDP1, TFDP2, MAX, CDC7, BRCA1, RBBP7, EZH2]
GO:2000402;negative regulation of lymphocyte migration;9.0;0.7671156992804218;0.7797984748205;9.405380701177911;296.2025090399906;7.697632086000634;0.009913631412617212;0.7898978880348613;[WASL]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[DCTN3, KIF14, BRCA1, GPR132, CCNB1, SIN3A, RAD21, CEP70, TOPBP1, CLASP1, FANCI, DONSON, CDC7, TUBG1, CKAP5, RAB11A, CDC25A, RINT1, CENPF, RAD51C, CDK6, PKIA, CENPJ, TAOK2, CDK2, MAPRE1, PAFAH1B1]
GO:0031061;negative regulation of histone methylation;10.0;0.7508913569872202;0.7906866903545304;9.430698509162202;697.779731799207;6.943860283624253;0.023354059662331516;0.7703503496879909;[MTF2, BRCA1, JARID2, SUPT6H]
GO:0051709;regulation of killing of cells of other organism;4.0;0.6393367784920305;0.5696683892460153;8.347590407030058;21.060629797292847;7.138016298065211;7.048803259791288E-4;0.6150384854347593;[P2RX7]
GO:0008286;insulin receptor signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;31.002284443533863;5.346256828837156;0.0010376185600805164;0.6484078228531001;[PTPRA, ATP6V0A2, ATP6V1F, IGF1R]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, CD80, LST1, SIRPG, CIB1, COMT, PKD2, FLCN, ADORA3, RPS6KA2, MYC, FNTB, NUP62, TRIM24, CTLA4, IL12A, JARID2, HRAS, RBM5, HAVCR2, KLF11, KLF13, IGFBP5, ATPIF1, EMP3, PDCD1LG2, SIRT2, NME1, SFRP1, TWSG1, GAL, TFDP1, KARS, TAX1BP3, B4GALT7, BECN1, THBS1, STK3, TP53INP1, LMNA, CSK, E2F7, TFAP2A, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, PER2, ITCH, IL6, CDK6, CNOT7, FAP, NFIB, CD9, MNDA, CNOT8, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[CDKN1A, WDR48, TFRC, ITGB3, CD80, SIRPG, CCNF, KIF14, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, LBH, MYC, FNTB, CTSH, SOX8, IL12A, ATP7A, SKP2, HRAS, CCR2, HLA-DPA1, HAVCR2, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, SPHK2, ITGA2, SPHK1, TBC1D8, ARNT, FLT3LG, PDCD1LG2, RUNX2, NME1, ERN1, SFRP1, CCNE2, IL23A, CCNE1, EPHA1, CARD11, HBEGF, HDAC1, FOXG1, EBI3, DERL2, NOLC1, CRIP2, THBS1, CORO1A, RELA, CCNB1, FZR1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, TBX1, MAP3K3, XBP1, CDC7, TSHR, PDCL3, CNOT6, CD4, IL6, CDK6, CNOT7, GPAM, SP1, CDK2, HLA-DPB1, KRAS, FAM98A, CNOT8, MNAT1, CCNJL]
GO:0001892;embryonic placenta development;5.0;1.0;0.7902410118609202;9.628524252492122;37.179255381886215;6.832634648514029;0.0012443562184742403;0.639662265535933;[SP3, ARNT, PKD2, BPTF]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[TBX1, JARID2]
GO:0001765;membrane raft assembly;5.0;0.8933024483968273;0.736892236059334;9.510741216835738;58.548893984641055;7.474488534686424;0.001959578791082312;0.6724867031240476;[CAV1, S100A10]
GO:0002739;regulation of cytokine secretion involved in immune response;9.0;0.8933024483968273;0.8428918493787028;9.54514264355307;176.7332134662955;7.212124270218933;0.0059151016051511626;0.7650689957573628;[KARS, ATG5]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[ITGB3, KIF14, THBS1, STK3, NEK1, NCKAP1L, RIPK1, CCL19, ECT2, MARK2, MAP3K3, DUSP5, PRNP, PDE6H, ZFP91, TNFRSF10B, TNFRSF10A, PILRB, OXSR1, MAPK8IP3, ERN1, P2RX7, CCDC88A, KARS, TAOK2, ADNP]
GO:0032148;activation of protein kinase B activity;12.0;1.0;0.9481203125901445;9.628524252492122;1099.1709144601095;6.311337724880743;0.03678826131738048;0.770882417347765;[CCDC88A]
GO:1901653;cellular response to peptide;6.0;0.6913464685778243;0.6687935468790567;8.798175950418692;225.6348642598113;4.473768719621393;0.007551795848581705;0.5519090529631041;[ERRFI1, PRNP, KLF11, XBP1, MAX, CAV1, PTPN22, CRHR1, TSHR, NFKB1, RELA, IGF1R, RAP1B, CDK5, SP1, MARS, PPAT, RAB13, TIMELESS, CSK, RAB8B]
GO:0046007;negative regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;666.9675842715774;7.379178354882098;0.022322804813714202;0.7926125360964777;[PRNP, PDCD1LG2]
GO:0045039;protein import into mitochondrial inner membrane;10.0;1.0;0.9152410118609203;9.628524252492122;627.9195794219177;7.697632086000634;0.021015903232318913;0.8088982747154926;[AGK]
GO:0048545;response to steroid hormone;5.0;0.6913464685778243;0.6359142461498324;8.935377071932177;60.25199573142884;4.388001897863968;0.0020165800738552384;0.51464363298064;[ERRFI1, OXTR, CDKN1A, ABCC2, PCNA, WBP2, ABCA3, CAV1, CAD, THBS1, RELA, SOX30, UBE2L3, AQP1, IL6, DDIT4, SDC1, KRAS, RBBP7]
GO:1900449;regulation of glutamate receptor signaling pathway;6.0;0.7763722522362496;0.7113064387082693;9.143016436710422;41.8512380110395;5.970411137910149;0.0014007232725606145;0.6284474158353811;[PRNP, NETO2]
GO:0050982;detection of mechanical stimulus;4.0;0.7369933605727446;0.6184966802863723;8.712233520617966;57.71052606361059;5.9928839937622085;0.0019315193712475664;0.5564763661386056;[ITGA2, PKD2L1, PKD2]
GO:0050860;negative regulation of T cell receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;309.61561130321576;6.8867018697843045;0.010362555874359037;0.7271862538851576;[DUSP22, PRNP, PVRIG, PTPN22]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TLE4, BCLAF1, XBP1, TFRC, PMM1, XRCC5, MTF2, ADAM23, JARID2, NEFH, BSPRY, SRM]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX, TBX1, ZNF35, AQP1]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[MYC, PKD2]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[GFI1, CD80, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, PABPN1, NLRP7, TBXA2R, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, NFKB1, BCR, P2RX7, IL6, TNIP2]
GO:0010243;response to organonitrogen compound;4.0;0.45240132074476547;0.47620066037238273;6.234015858980763;25.42702214820504;3.12938525411714;8.510195484661687E-4;0.4100369074268474;[ERRFI1, BTG2, OXTR, CDKN1A, ITGB2, PTPN22, BRCA1, PKD2, IGF1R, AQP1, EFTUD2, SIN3A, PPAT, FUNDC1, NPPA, CFL1, ATP7A, RAB8B, ACTR2, KLF11, SEC13, ABCC2, FCER1G, IGFBP5, ITGA2, CAD, SIRT2, NME1, SFRP1, GAL, XRN1, TIMELESS, PIK3C3, MAN1B1, PCNA, MAX, DERL3, ITPR2, DERL2, CRHR1, RELA, HSP90B1, RAP1B, GNG2, UBQLN1, SCAP, NLRP3, CSK, CYC1, EIF2B4, PRNP, XBP1, TOR1A, SDF2L1, WFS1, EDEM1, RHBDD1, CAV1, SYVN1, ERLIN2, CRLS1, TSHR, NFKB1, NFKBIA, P2RX7, IL6, COL1A2, RAD51, RNF103, NPLOC4, P2RX4, CDK5, SP1, MARS, PSMC1, RAB13, SDC1, CD9, EZH2, CPEB4]
GO:0015991;ATP hydrolysis coupled proton transport;10.0;1.0;0.9152410118609203;9.628524252492122;157.7498630086325;6.375876246018314;0.005279745949239413;0.7413036195908642;[ATP6V0A2, ATP6V1F]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SMG1, IGF1R, MKNK2, TRIM24, RIPK1, CSK, MARK2, PDGFRB, MAP3K3, CAD, EIF2AK3, VRK1, VRK2, CLK4, EIF2S1, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, TAOK2, EPHA1, CSNK1G2]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[NIPBL, IRF4, ITGA2, CEBPG, PLAUR, SIRT2, NME1]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[P2RX7, NCKAP1L, CORO1A]
GO:0060964;regulation of gene silencing by miRNA;8.0;0.7369933605727446;0.7434966802863723;9.158520623246385;63.198578554006836;5.8067817141283475;0.0021151995491745495;0.6719590869034888;[FXR1, NCOR2, IPO8, NCOR1, POLR2B, H3F3A, POLR2G, TNRC6A]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[PER2, NFKBIA, ZNF462, SIN3A, SUMO3, ZFP90]
GO:0045332;phospholipid translocation;8.0;1.0;0.875;9.628524252492122;116.86638763413639;6.641579411751319;0.003911412821194078;0.7146506799819907;[P2RX7, TMEM30A]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[VIL1, CSNK2A1, PLAUR, TNFRSF10B, TNFRSF10A, NLRC4, RFFL, UBE2Z, THBS1, AQP1]
GO:0070885;negative regulation of calcineurin-NFAT signaling cascade;10.0;1.0;0.9152410118609203;9.628524252492122;339.10982455209705;7.292166977892469;0.011349700648730492;0.7881627702307852;[PRNP, HOMER3]
GO:2000676;positive regulation of type B pancreatic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.390779266560578;0.00434501821119318;0.8253454670833372;[IL6, EIF2S1]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[NLRP12, DIABLO, EIF2AK3, NLRP3, CTSH, TNFRSF10B, RIPK1, TNFRSF10A, NLRC4, BID, HSPE1, BBC3]
GO:2000678;negative regulation of transcription regulatory region DNA binding;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;47.570979032210005;6.7325511899570465;0.001592157857106472;0.6674232935401965;[PER2, SIN3A]
GO:0016973;poly(A)+ mRNA export from nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;122.0533615230405;7.004484905440688;0.004085016169282269;0.7734506956670166;[NUP93, NXF3, PABPN1, POLDIP3, THOC2]
GO:0015986;ATP synthesis coupled proton transport;12.0;0.8933024483968273;0.8947715367885583;9.60254876608886;8770.205790009275;6.444869117505266;0.2935308951188351;0.7777112189764279;[ATP6V0A2, ATP5J, ATP5I, CYC1, COX5B, ATP5O, ATP5F1, ATP5L]
GO:0035590;purinergic nucleotide receptor signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.195621953761602;6.641579411751319;9.102129923216596E-4;0.6905700452391912;[P2RX7, P2RX4]
GO:0090140;regulation of mitochondrial fission;7.0;0.8653626801206646;0.7836007053175329;9.34084218004034;36.654343885932605;6.641579411751319;0.0012267879030943493;0.6905700452391912;[TMEM135, DDHD2]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[EGLN2, NNT, TXNRD1, PRDX1, TXNDC11]
GO:0046785;microtubule polymerization;7.0;1.0;0.8509193652572005;9.628524252492122;97.26999823215544;7.292166977892469;0.0032555393035152377;0.7238411236270654;[CENPJ, ZNF207, FBXO5, CKAP5]
GO:0090141;positive regulation of mitochondrial fission;8.0;1.0;0.875;9.628524252492122;158.83836540067767;7.069023426578259;0.005316177144712613;0.7365101867784198;[DDHD2]
GO:0000147;actin cortical patch assembly;7.0;1.0;0.8509193652572005;9.628524252492122;89.93282460404566;7.9853141584524145;0.0030099707052099636;0.7592887026755414;[WIPF2, WASL]
GO:0055015;ventricular cardiac muscle cell development;7.0;1.0;0.8509193652572005;9.628524252492122;69.56390858866273;7.379178354882098;0.002328241417009372;0.728290889492758;[CCNB1, LMNA, ATG5]
GO:1990737;response to manganese-induced endoplasmic reticulum stress;7.0;1.0;0.8509193652572005;9.628524252492122;109.00578564445789;8.67846133901236;0.0036483255466820412;0.7947362817240173;[EIF2AK3, EIF2S1]
GO:0006809;nitric oxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.09966064176743;7.212124270218933;0.008069388666072628;0.6919486831672181;[GCHFR, RORA]
GO:0035584;calcium-mediated signaling using intracellular calcium source;8.0;1.0;0.875;9.628524252492122;30.117246255164275;6.781341354126479;0.0010079971283984438;0.7217981122146513;[PRNP, CCL20, DEFB1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, CIITA, BTG2, ZNF175, GFI1, OTUD7B, IKZF2, YY1, FLCN, NIPBL, SIN3A, C1QBP, MYC, SAP130, WWC3, EP300, SOX8, LRRFIP1, HIF1AN, CIC, SOX6, JARID2, ZNF564, DACT1, TLE4, KLF11, KLF12, PEG3, RFC1, ZBTB32, ARID1A, HCFC2, SIRT2, ZFP90, DUSP22, NCOR2, EID1, BRMS1, NCOR1, RBL1, TBL1XR1, CCNE1, NFX1, MTF2, HOXB4, TIMELESS, LCOR, PPID, MCPH1, HDAC3, ZNF350, HDAC1, MAX, FOXG1, LRP8, RELA, MTDH, RXRA, BAG3, TPR, HIVEP1, HESX1, SUDS3, RBBP7, MTA2, E2F7, ZNF189, E2F8, BPTF, IRX1, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, WFS1, CAV1, NFKB1, PER2, GFI1B, CNOT7, NFIA, CNOT1, NFIB, NFIC, PKIA, SP3, CDK2, NFE2L3, TAF7, ZNF136, EZH2]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[SFRP1, XRCC5, MTF2, HOXB4, A2M, JARID2, RUNX2]
GO:0001569;branching involved in blood vessel morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.375876246018314;0.0017907488225476112;0.6769819729871445;[RBM15]
GO:0051901;positive regulation of mitochondrial depolarization;8.0;1.0;0.875;9.628524252492122;107.42585434118669;7.57984905034425;0.0035954466678074135;0.7626338329336335;[P2RX7]
GO:2000330;positive regulation of T-helper 17 cell lineage commitment;14.0;1.0;0.9759193652572005;9.628524252492122;3030.274946811922;8.390779266560578;0.10142057539939929;0.9050242071602486;[IL23A, IL12RB1]
GO:1905098;negative regulation of guanyl-nucleotide exchange factor activity;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;99.11376152007192;8.16763571524637;0.003317248401482572;0.7408135829017477;[MET, EIF2S1]
GO:0032060;bleb assembly;6.0;1.0;0.8231203125901445;9.628524252492122;58.56724312331254;7.474488534686424;0.001960192920240494;0.7053660038532718;[P2RX7, EMP3]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[BECN1, ERRFI1, PCNA, TFRC, ITPR2, PTPN22, BRCA1, RELA, HSP90B1, AQP1, EFTUD2, RAP1B, SIN3A, PPAT, MYC, TP53INP1, ECT2, DCPS, PRNP, ABCC2, CAD, NFKB1, NME1, SETX, SFRP1, IL6, RAD51, P2RX4, XRN1, DDIT4, CDK2, TIMELESS, EZH2]
GO:0033273;response to vitamin;6.0;0.6664901433067099;0.6563653842434994;8.438940185618286;22.816494584803845;5.311165509025885;7.636475402414068E-4;0.5947335637161829;[BECN1, CD4, SFRP1, SETDB1, NNT, ITGA2, AQP3, RELA]
GO:1902938;regulation of intracellular calcium activated chloride channel activity;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;199.08006120767874;8.67846133901236;0.006663030488198;0.8400575416471059;[PRNP]
GO:0006900;vesicle budding from membrane;5.0;0.7980440201809971;0.6892630219514189;9.089527751759436;39.266540306241254;6.444869117505266;0.00131421576645793;0.6198319182472036;[P2RX7, SEC13, WASL, FNBP1L, S100A10]
GO:0006906;vesicle fusion;6.0;0.6799073451904818;0.6630739851853854;8.563813515499694;63.097974703971886;5.192106149009898;0.0021118324288514666;0.5886448625081389;[GOSR1, SYT15, STX11, SYTL3, TAPBP, RPH3A, VAMP8, RAB20, VPS41, VPS8, VPS11, STX5, SNAP29, SPG11, VAMP5, RAB8B, SEC22C]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[P2RX7, FLT3LG, VPS54, KRAS, CORO1A, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, HSPH1, BAG3, BAG1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, WFS1, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, BTG2, CDKN1A, DOCK8, KIF14, BRCA1, AATF, NNT, SIN3A, NUP62, CASP2, CTSH, HRAS, TSC22D4, FGA, DFFA, FCER1G, SPHK2, SPHK1, FGG, PLAUR, YWHAZ, DDB1, ITPKB, CREB3, PTRH2, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, TBX1, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TRIM32, MAD2L1]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[HRK, YWHAB, UBE2Z, BBC3, FLCN, AKAP13, RPS6KA2, C1QBP, MYC, ARL6IP5, CASP2, CTSH, CTLA4, IL12A, RBM5, PDGFRB, KLF11, DFFA, ENDOG, FBXO18, RPS7, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, SFRP1, GAL, BRMS1, TFDP1, TFDP2, PTRH2, ARHGEF1, ARHGEF5, ITGB3BP, PPID, DIABLO, NLRC4, THBS1, STK3, ABR, BCLAF1, CCL5, UBD, TP53INP1, TP53BP2, NLRP3, RIPK1, SUDS3, ZNF622, ECT2, BID, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, G0S2, TNFRSF10B, TNFRSF10A, HSPE1, EIF2S1, P2RX7, NLRP12, IL6, FAP, CDK5, MNDA, PDCD1, SERINC3]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[P2RX7, CD151, IL23A, ELF4, DOCK8, EBI3, DOCK2]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[RAB3B, VPS18, VPS33A, VPS33B, VPS11, VPS45, RABEPK, RAB8B]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, PCNA, NCF1, TXNRD1, GPX7, ATP2A2, PYCR1, VRK2, PKD2, EIF2S1, SIRT2, RELA, AQP1, SETX, IL6, CCS, PRDX1, TP53INP1, PXMP2, CDK2, ECT2, NFE2L1, EZH2]
GO:0071500;cellular response to nitrosative stress;4.0;0.8933024483968273;0.6966512241984136;9.377209824211215;38.53895173814625;8.390779266560578;0.001289864031870989;0.6791048419030481;[ATG5]
GO:0032057;negative regulation of translational initiation in response to stress;10.0;0.8436909121759173;0.837086467948879;9.541512875502493;3170.177670468063;8.390779266560578;0.10610299365589344;0.8443458537639685;[EIF2AK3, EIF2S1]
